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There are many sources of imprecision in delivering external beam radiotherapy.
Some of the errors can be eliminated with image guidance, but still, some inaccu-
racies have to be accounted for by using margins around the target volume. For
mobile targets, such as the bladder, the internal motion of the target can be even
the most important source of imprecision. Treating such targets with radiation
therapy is challenging, since the margins needed to account for the possible target
position variation inevitably include some normal tissue, which can lead to serious
side-effects, limiting the treatment dose and preventing dose escalation. Adaptive
radiation therapy (ART) addresses this challenge. In bladder ART, the target vol-
ume is modified daily to accommodate the daily bladder volume as conformally
as possible, but without compromising dose coverage of the bladder. Different
strategies for bladder ART have been suggested, but there is not yet a consensus
of which strategy is the optimal one.
In this study, the adaptive radiotherapy methods applied in Helsinki Univer-
sity Central Hospital (Helsinki method) and Aarhus University Hospital (Aarhus
method) for bladder cancer were compared. The treatment according to both
methods was simulated for 10 patients in three different ways. There was no statis-
tically significant difference between the methods in terms of the chosen planning
target volume size. The selected alternative planning target volumes were more
evenly distributed in the Aarhus method. Comparison of the modified methods
with centroid registration suggested a possibility of a more even selection of treat-
ment volumes if the current Helsinki method plan selection volumes (PSVs) were
expanded with a 3-mm margin. However, for both methods, the smaller planning
target volumes were selected more often in the actual treatment than in this sim-
ulation, suggesting that utilizing the bladder contours in the plan selection in the
simulation affected the selections in an unexpected way.
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Ulkoisessa sädehoidossa on epätarkkuuden lähteitä. Jotkin näistä virhelähteistä
voidaan poistaa käyttämällä kuvantaohjausta, mutta jotkin epätarkkuudet täy-
tyy huomioida käyttämällä marginaaleja kohdealueen ympärillä. Liikkuville
hoitokohteille, kuten virtsarakolle, kudosten liike potilaassa voi olla jopa suu-
rin epävarmuuden lähde. Tällaisten kudosten sädehoito on haastavaa, sillä
kohteen mahdollisen liikkeen kompensoiviin marginaaleihin sisältyy väistämättä
myös normaalia kudosta. Tämä voi johtaa vakaviin sivuvaikutuksiin, jotka ra-
joittavat käytetyn säteilyannoksen suuruutta. Ongelmaa pyritään ratkaisemaan
adaptiivisella sädehoidolla. Virtsarakon adaptiivisessa sädehoidossa kohdealuetta
muokataan joka hoitokerta kattamaan rakon tilavuus mahdollisimman pienellä
kohdealueen tilavuudella, kuitenkaan tinkimättä rakon annoskattavuudesta. Virt-
sarakon adaptiiviseen sädehoitoon on ehdotettu monia toteutustapoja, mutta
parhaasta mahdollisesta menetelmästä ei ole vielä päästy selvyyteen.
Tässä tutkimuksesssa verrattiin Helsingin Yliopistollisessa Keskussairaalassa ja
Aarhusin Yliopistollisessa Sairaalassa (Engl. Aarhus University Hospital) käytet-
tyjä virtsarakon adaptiivisia sädehoitomenetelmiä. Menetelmien mukainen hoito
simuloitiin kymmenelle potilaalle kolmella eri tavalla. Menetelmien välillä ei
ollut tilastollisesti merkitsevää eroa valitun kohdealueen koossa. Vaihtoeh-
toisia kohdealueita valittiin tasaisemmin Aarhusin menetelmässä. Muokattujen
menetelmien vertailusta kävi ilmi, että Helsingin menetelmän mukaisten suunnitel-
manvalintavolyymien (Engl. plan selection volume, PSV) laajentaminen 3 mm
marginaalilla voisi johtaa tasaisempaan vaihtoehtoisten kohdealueiden valintaan.
Pienempiä kohdealueita valittiin kuitenkin molempien menetelmien tapauksessa
todellisessa hoidossa simulaatiota enemmän, joten rakon ääriviivojen käyttö suun-
nitelmanvalinnassa saattoi vaikuttaa valintoihin odottamattomalla tavalla.
Avainsanat: virhelähteet, adaptiivinen sädehoito, virtsarakon syöpä, hoidon sim-
ulaatio
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11 Introduction
In external beam radiotherapy, radiation is produced with a linear accelerator and
delivered to the target volume based on positional information of the computerized
tomography (CT) image of the patient. The aim is to treat the target volume
with a dose that is high enough to kill the malign cells while keeping the dose to
healthy tissue at minimum. Fulfilment of this goal is challenging, mainly because of
geometric inaccuracies in the treatment process. The total dose is usually divided
into smaller fractions, and therefore, the daily positional variation of the target poses
an additional challenge in the case of moving tissue.
The accuracy can be improved with careful patient positioning and maintenance
of the imaging and treatment devices [1]. The movement of the target can be
attempted to be restricted or compensated for with tracking [2]. Image-guided
radiation therapy solves many of the problems in precisely delivering radiation to
the target. However, there is always some remaining inaccuracy, which is taken into
account by adding margins to the treatment volume [2]. In this thesis, the different
sources of imprecision in the radiation therapy process are examined. The ways
to deal with these sources of error are addressed and the remaining problems are
discussed.
The urinary bladder is a mobile organ and with its changing volume a problem-
atic target for radiation therapy [3; 4]. The position and volume of the planning
target volume varies from day to day not only due to the gradual changes of the
tumour and the surrounding normal tissues, but also because of the changes in
urinary bladder dimensions that cannot be avoided by instructing the patients to
empty their bladder [4; 5]. Also the adjacent organs change the bladder shape [6].
Thus, daily imaging is required.
Image guidance enables adjusting the patient’s position on the treatment ma-
chine immediately before the treatment based on the imaging information acquired [2].
The patient can be positioned to the treatment by registering the treatment planning
computerized tomography image and the image acquired on the treatment machine.
In this registration the patient’s anatomy (e.g. bones or soft tissues) in the treatment
planning CT is matched to that of the image acquired in the treatment.
In radiation therapy of the bladder, some problems remain to be solved even
with image guidance. The tolerance of the surrounding normal tissues restrain the
dose that can be given to the target volume, since large margins need to be added
to the target volume in order to achieve adequate dose coverage to the bladder [7].
Adaptive radiation therapy (ART) aims at increasing the precision of the treatment
while minimizing the treated volume. In adaptive radiotherapy, the target volume
is adapted to the daily target volume shape and position [8]. Different strategies
for adaptive radiation therapy of the bladder have been suggested, but it is still
unclear, what would be the optimal way to minimize the treated volume without
compromising the target coverage.
Two methods for image-guided adaptive radiotherapy of the bladder have been
recently proposed [9; 10]. In the method used in Helsinki University Central Hos-
pital (Helsinki method), four treatment planning CT images with different bladder
volumes are acquired and based on the bladder volumes delineated on the images,
a set of treatment plans is made [9]. The plan of the day is chosen based on the
visible extent of bladder wall in cone-beam computed tomography (CBCT) images.
In the method used in Aarhus University Hospital (Aarhus method) the treat-
ment of the first week is given conventionally. The treatment plan for the first week
is made based on one treatment planning CT image with margins large enough to
account for the changes of the bladder volume. CBCT-images of the patient are
acquired every day during the first week and three alternative planning target vol-
umes are constructed with Boolean operations performed on the bladder contours
of the four different CBCT images and the treatment planning CT image [10].
The aim of this study is to compare these two methods for adaptive radiation
therapy of the bladder in terms of hitting the target and saving the surrounding
normal tissues. This is done by simulating the treatment up to the point where the
target volumes for the daily treatments are chosen. The simulation is repeated with
three ways, with the aim of critically analysing which factors have an effect on the
results and to evaluate the pros and cons of the methods.
There are situations that the lymph nodal areas surrounding the bladder need to
be included to the target volume. The usual procedure in these cases is to register
the images according to the bony anatomy. In this study, the treatment of the
bladder and the lymph nodal areas is simulated, positioning the patient according
to the bladder. The margin needed to account for this positional error induced to
the lymph nodes is calculated.
Chapter 1 is an introduction. In Chapter 2, the theoretical background of the
study is addressed. The central idea and concepts of radiation therapy are reviewed
and the ways to classify errors in radiotherapy are introduced. The ways to min-
imize the imprecisions and to compensate for the remaining inaccuracies are also
described. After this, the sources of inaccuracy present during the course of radio-
therapy treatment are reviewed, making a division to the errors in the treatment
simulation and those in the treatment delivery. In addition, radiotherapy of the uri-
nary bladder cancer is reviewed and the adaptive radiotherapy methods of Helsinki
[9] and Aarhus [10] are introduced. Chapter 3 describes the methods of the study,
discussing the patients, the three different ways to simulate the treatment, and simu-
lation of the treatment with the lymph nodes included. Also the statistical methods
used in the study are reviewed. Chapter 4 presents the results of the study and
Chapter 5 discusses the findings. In Chapter 6, the conclusions of the study are
reported.
32 Background
2.1 Introduction to radiotherapy
In this chapter, the aim and principles of external beam radiotherapy are reviewed.
First, the fundamental idea behind radiotherapy, the dose–response relationship,
is clarified. Second, the radiotherapy treatment process is briefly reviewed. Fur-
thermore, the definition and classification of errors are introduced and the ways to
minimize errors as well as the principle of accounting for the errors with margin
addition are described.
2.1.1 Dose–response relationship
The goal of external radiotherapy is to give the patient a radiation dose which
maximizes the probability for tumour local control, yet minimizing the side effects
for normal tissues. When the treatment fulfils these two goals in the best possible
manner, its therapeutic ratio is optimized. When planning the treatment one must
take into account not only the therapeutic dose to the tumour but also the tolerance
of the normal tissues. The distance between the dose producing the tumour control
and the dose causing unwanted side effects is usually narrow. Usually, megavoltage
(MV) photons or electrons are used in the radiation therapy. Both the electrons and
the photons interact in the tissue ionizing the atoms on their way. The recombination
of these ionized atoms provides energy for the production of highly reactive chemical
radicals. These mostly water-based radicals can then attack the DNA and other
critical structures of the cell nucleus, which interferes with cell reproduction thus
sterilizing the cell.
If a cancer cell can form a number of copies of itself by dividing itself, it is
called a clonogenic unit [11]. The curation of the tumour can be accomplished only
by destroying each individual clonogenic unit of the tumour. It is essential that
the entire target volume receives the prescribed dose as even a small volume of the
target not receiving the total dose might contain living tumour cells. If these cells
did not achieve the prescribed dose, this might lead to local recurrence.
The effect of radiotherapy on the normal tissues and the tumour can be described
with dose–response relationship curves. The term tumour control probability (TCP)
means the dose–response relationship of the tumour and the term normal tissue
complication probability (NTCP) is used for the normal tissues, respectively. The
curve presents the probability of a given reaction as a function of the absorbed
dose D. Probability of uncomplicated cure (PUC) describes the probability that
the tumour is cured without having any side effects. It can be calculated with the
formula:
PUC = TCP (1− NTCP) (1)
The absorbed dose in matter is defined as the energy that has been absorbed
from ionizing radiation to a certain point of matter per unit mass. Its unit is gray
(Gy).
4Figure 1: Dose–response relationship curves. The TCP is the tumour control prob-
ability describing the radiation response of the tumour. NTCP is the normal tissue
complication probability describing the response of the normal tissues to radiation.
The PUC curve describes the probability of uncomplicated cure. However, in clin-
ical situations, the dose maximizing the value of PUC may lead to unacceptable
side-effects.
The dose–response relationship curve of both normal tissue and the tumour has
approximately a logistic form [11]. An example of the dose–response relationship
curves for normal tissues and tumour is shown in Figure 1. The form of the curve
shows that the probability for a response to the radiation is very modest with small
doses. Also, one can see that with doses higher than some threshold dose, which
depends on the tissue, the probability of the response grows rapidly.
These dose–response relationship curves are typically steep, and thus it is im-
portant to deliver the precisely correct dose to the precisely correct target. If the
actually received dose is smaller than expected, this can reduce the probability of
the cure. The normal tissue complication probability curve often lies close to the
tumour control probability curve and thus, the target dose cannot be escalated more
than to the threshold dose of the normal tissue complication probability curve. The
precision of the dose as well as the geometrical precision while delivering the dose is
important. The geometrical deviation between the planned and the actual received
dose distribution can lead to both smaller tumour dose and larger normal tissue
dose [12].
52.1.2 Radiotherapy treatment process
The different phases of the radiotherapy treatment are the treatment planning and
treatment delivery. In the treatment planning, a planning computerized tomography
image is first acquired. Then the target volume and the adjacent normal structures
are delineated in the CT image and a treatment plan is made. The treatment
delivery phase comprises the treatment, where several treatment fractions are given.
Most often a medical linear accelerator (linac) is used for producing the radiation
and directing it at the patient. The linac accelerates electrons, which can be used
to treat the patient or to produce photons. Photons are attenuated with only about
a factor of 2 in passing through the body and thus can treat deep-lying tumours
[13]. The absorbed dose of photons builds up over the first a few centimetres which
is useful for limiting the dose to the sensitive layers of the skin. More superficial
targets can be treated with electrons, which penetrate the body only to a distance
of a few centimetres [13]. This reduces dose to the deeper-lying critical structures.
Most modern linacs have an isocentric set-up with the treatment head, i.e.
gantry, rotating 360 degrees around one certain point; the isocentre [13] (Figure
2). This is the point of intersection of the gantry axis and the collimator axis, which
is moving in the vertical plane [14]. The treatment couch also rotates with respect to
the isocentre, around an axis perpendicular to the couch surface and parallel with
the collimator axis. The couch is a flat, even board that can be moved in three
orthogonal directions. It is made of a material that minimally attenuates radiation.
The location of the isocentre is indicated by the lasers on the sides of the treatment
room.
In the treatment simulation, a computerized tomography scan is acquired, the
patient being in the treatment position. The treatment position is chosen so that it
is as suitable as possible for image acquisition and treatment [13]. This means that
the position is easily reproducible and comfortable for the patient. Being able to
reproduce and hold the position can be aided by using different patient positioning
systems and rigid immobilization devices [12; 13].
During treatment simulation, the position of the isocentre in the patient is chosen
from the CT images and sent to the laser indicators on each side of the patient. The
projections of the isocentre location on each side of the patient are tattooed to the
spots shown by the lasers. The initial patient positioning during the treatment is
based on these tattooed marks.
The next step in the radiotherapy treatment process is to delineate the target
volume and the adjacent critical normal structures to the treatment simulation CT
images. To get standardized, reproducible procedures in this task, international
organizations have published recommendations for the purpose. In the following, the
most common recommendations by International Commission of Radiation Units
and Measurements (ICRU) are presented. A radiographer delineates the critical
normal tissues surrounding the target in the planning CT image. After this the
radiation oncologist delineates the gross tumour volume (GTV) and defines the
clinical target volume (CTV) and the planning target volume (PTV).
The gross tumour volume is the primary tumour volume containing the maximum
6Figure 2: A linear accelerator with an isocentric set-up, Elekta Versa HD in HUCH.
The gantry of the linac rotates a whole circle around the isocentre. The treatment
table can also be moved and rotates around the vertical axis going through the
isocentre. Opposite to the gantry there is a flat panel MV radiation detector for
MV imaging. On the right there is an X-ray tube and on the left there is a detector
for kV imaging. The imaging equipment is turned off the way of the treatment
radiation.
7tumour cell density. The shape, size and location of the GTV can be observed by
clinical examination, e.g. palpation or imaging. The clinical target volume contains
the tumour plus the suspected microscopic growth around the tumour, which cannot
be observed, palpated or visualized. The CTV needs to be derived from information
of the characteristics of similar tumours in the past [15]. To account for the small
deviations between the planned and delivered treatment, the clinical target volume is
expanded with a safety margin. The planning target volume is the volume to which a
high dose is directed merely in order to ensure that the CTV receives adequate dose
despite the geometric errors in the treatment [16]. Delineating the PTV, one must
have knowledge of the possible uncertainties and variations in the tumour location
and machine parameters [17]. The treated volume is the volume which gets the full
prescribed dose. The irradiated volume is defined as the volume receiving a dose
that is considered significant for the normal tissue tolerance. The target volumes
are illustrated in Figure 3.
Figure 3: Definition of volumes in radiotherapy. Figure modified from Ref. 19.
The total treatment dose is usually divided to smaller fractions. This way it is
possible to enable the healthy tissues to repair the damage produced by the radiation
while the more radiosensitive tumour cells are irreversibly damaged. The radiation
fields are aimed at the target of the treatment from many different directions so
that only the target receives the prescribed total dose and the surrounding healthy
tissues only get a part of the dose [19].
After the radiation oncologist has defined the planning target volume and as-
signed the dose and fractionation to the PTV, the physicist makes the treatment
8plan. The field set-up that gives the most uniform dosage to the PTV minimis-
ing the dose to the normal tissues is chosen. According to ICRU recommendations
the PTV dose should be 95–107% of the dose prescribed by the radiation oncologist
[18]. In addition to the constraints set to the PTV dose, the normal tissue tolerances
are taken into account when planning the treatment. There are specific tolerance
criteria for every organ.
The treatment is planned with a computerized treatment planning system (TPS),
which calculates the dose distribution in the patient by utilizing the tissue density
information from the planning CT image. In the case of conformal radiotherapy, the
physicist chooses the number and directions of the beams. The beams are formed
with the collimators and the multi-leaf collimator (MLC). The latter has leaves that
are set to certain positions according to the shape of the target. It is possible to
control the relative amount of radiation produced by each of the beams by adjusting
field weights.
When making an intensity-modulated radiation therapy (IMRT) plan, the treat-
ment planning process is inversed. The physicist sets the normal tissue tolerance
criteria and the field directions to the treatment planning system. The TPS opti-
mizes the field weights and intensity patterns from each field that produce the most
conformal and uniform dose filling the criteria. The intensity pattern in the fields is
modulated by the means of closing and opening the MLC leaves during irradiation.
The technique is especially powerful in sparing of normal tissues from the treatment
dose in the case of concave targets. Another method with a similar optimization
process as in IMRT is volumetric-modulated arc treatment (VMAT), which utilizes
beams that turn along an arc during the radiation production. VMAT is especially
practical for approximately round targets.
Each treatment fraction begins with patient set-up to the treatment machine.
The patient is positioned to the treatment machine in the same way in the treatment
delivery as in the treatment simulation CT. It is important to make a good docu-
mentation of the patient positioning and immobilization devices in the simulation
in order to be able to reproduce the position also during the treatment. At present,
in the majority of treatments, the target volume is further localized by imaging on
the treatment machine immediately before each fraction. The imaging can be done
with planar kV or MV imaging or different 3D-imaging methods, such as cone-beam
CT imaging. Depending on the target and on the imaging method, either the target
or a surrogate, e.g. the surrounding bony anatomy, is imaged. The possible mis-
alignments of the beams that would be left undetected without imaging can then
be corrected with translations and rotations of the treatment table. The prescribed
single fraction of the total radiation dose is then given with the treatment machine.
2.1.3 Definition and classification of errors
In this thesis, the word ’error’ does not mean a major mistake in the treatment that
should have been detected by quality assurance procedures, i.e. a gross error, but
instead the small deviations between the planned and delivered treatment. The aim
is always to minimize these errors, but usually they cannot be totally eliminated.
9The remaining errors are accounted for in the PTV formation, by adding a safety
margin to the CTV.
Errors can be classified as random and systematic. Systematic errors have their
origin in the treatment preparation and will influence all treatment fractions in
an identical way [16; 20–22]. These errors mainly result because the target shape
and position with respect to the isocentre are based on a single measurement [20].
Random errors, on the other hand, take place in the treatment delivery and do not
have a systematic direction or magnitude [21; 22].
Random and systematic errors affect the dose distribution differently [21]. Ran-
dom errors blur the dose distribution [1; 20]. In contrast, systematic errors cause a
systematic shift of the dose distribution in respect to the target [16; 20; 21] (Figure
4). The effect of random errors, i.e. blurring of the dose distribution is easier to pre-
dict for each individual patient than the effect of systematic error [16]. Systematic
errors have a much larger impact on the target dose than treatment delivery errors
[21–23].
Figure 4: (A) The 95% isodose level of the dose distribution (green line) tightly
surrounds the PTV when the dose is delivered without geometric errors. (B) Sys-
tematic deviation in the daily alignment of the field to the PTV causes a shift in
the dose distribution with respect to the PTV. (C) Random errors in the alignment
of the dose distribution and the PTV cause blurring of the dose distribution. The
green 95% isodose level no longer surrounds the PTV. The PTV is the volume de-
lineated with a red contour. The different dose levels, that is, the isodose lines are
marked with different colours. For illustrative purposes, the errors in the isocentre
position are 1 cm, which is an unrealistic error in a real RT treatment.
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The variations in the treatment can also be classified as internal and external
variations [17]. Internal variations are differences in the position, size and shape
of the CTV [17]. Not all tissues are rigidly attached to the bony anatomy and
thus, variations in the CTV positions can occur either directly or indirectly as the
CTV is pushed by other moving organs and tissues. Internal variations patient and
site-specific and can be affected by patient preparation protocols such as voiding
instructions. External variations are deviations in the patient positioning and in the
beam positioning. The external variations are affected by the patient positioning
methods, the mechanical uncertainties of the equipment, dosimetric uncertainties
(e.g. penetration of the beam), transfer errors from CT and simulator to the treat-
ment unit, and human factors [17]. As well as variations between different treat-
ment fractions (interfractional variation), there can be movement occurring during
a treatment fraction (intrafractional variation). Both internal variations, such as
organ motion, and external variations, such as patient movement relative to the
beam position occur also during the treatment fractions.
2.1.4 Image-guided radiotherapy – minimizing errors
Safety margins are applied to account for geometric uncertainties in radiation ther-
apy. In many cases these margins overlap organs at risk, which limits dose escalation
[2]. Image-guided radiotherapy aims at improving the accuracy by imaging tumours
and critical structures on the treatment machine immediately prior to irradiation
[2].
There are multiple options for image guidance technologies available, including
imaging devices both integrated and not integrated within the treatment room.
A non-integrated option is a CT scanner outside the treatment room. Options
that are integrated to the treatment room include kilovoltage (kV) X-ray imaging,
active implanted markers [24; 25], ultrasound [26], megavoltage (MV) single slice
CT (Tomotherapy) [27], conventional CT [28] and kV [29] and MV cone-beam CT
[30]. Image guidance requires an imaging method to visualize the anatomy used as a
surrogate for the target movement, a reference dataset and a method for correction
of the error (e.g. translations of the treatment couch).
The information achieved from the imaging methods available on the treatment
machine enables correction of the small deviations that are not visible just by com-
paring the location of the tattooed markings on the patient to the position of the
laser lines. The imaging method affects what corrections can be made. If the target
remains in a rigid position according to the bony anatomy, it is enough to visu-
alize the bones for example with two-dimensional planar imaging. If the target is
a soft tissue changing position with respect to the bones, 3-dimensional imaging
method with the ability to distinguish the soft tissues is the only option. Adequate
visualization is always a prerequisite for corrections.
The errors that can be corrected with image guidance depend on the imaging
method used and the strategy used for correcting the errors. There are three different
types of strategies for correction of errors: Oﬄine corrections, online corrections and
intrafraction corrections [2]. In oﬄine correction the reaction to the image taken is
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delayed to the subsequent fraction, whereas in online correction the reaction comes
immediately after imaging, before the treatment. Intrafraction corrections are made
with multiple images and corrections during each fraction.
The idea behind oﬄine correction is that the margin selection is predominantly
affected by systematic errors and less by random errors [2]. In oﬄine correction one
aims to correct the mean error of a patient without correcting the daily random
variations. The advances in online imaging have made online corrections immedi-
ately after imaging feasible. The advantage of online correction is that it efficiently
accounts for both systematic and random errors. A challenge is that the analysis
and corrections should be performed quickly and the time pressure can affect the
accuracy of the procedure [2].
Adaptive radiotherapy is image-guided RT taking a step further. In image-
guided RT, the possible imaged deviations are corrected by moving the patient, but
in addition, adaptive radiation therapy involves modifications to the treatment plan
based on the information in the images. Yan et al. defined the adaptive radiation
therapy as ’A radiation treatment process where the treatment plan can be modified
using a systematic feedback of measurements’ [8].
In oﬄine ART a single adaptive treatment plan is generated using various re-
peated CT and/or CBCT scans [9]. However, adaptive radiotherapy can also be
implemented on-line [8], modifying the plan daily according to imaging information.
Online ART can in practice mean choosing the daily treatment plan from a library
of pre-planned treatment plans based on CBCT imaging [9]. Adaptive radiotherapy
is a solution for targets with organ motion being a significant source of error, such
as the urinary bladder. Adaptive radiotherapy of the bladder is discussed later in
this text. One remaining improvement would be online re-planning using volumetric
imaging data [2]. In re-optimization of the treatment, the same problem as with
also other online corrections is encountered, namely time pressure, which at present
makes the re-planning mostly infeasible in clinical practice [2].
2.1.5 Margin recipies – accounting for errors
There are different approaches available for growing the PTV based on the GTV.
In this chapter, the basic concepts of PTV formation are briefly addressed and the
margin recipe of Van Herk et al [21], which was used to form the margin for lymph
nodes in this study, is explained.
Most of the sources for systematic error can be assumed to be normally dis-
tributed and independent of each other and thus can be combined in quadrature to
produce the combined systematic error Σ [15; 31]. Here the standard deviations of
the systematic error component i will be denoted by Σi.
Treatment delivery error components are also assumed to be normally distributed
and independent. Treatment delivery errors generally take a different value at each
treatment fraction and thereby have a Gaussian nature [15]. Thus, they also can be
added in quadrature to form the total random error [31]. Also the delineation error is
assumed to be Gaussian because of the lack of a more realistic model [15]. Treatment
delivery error arises from random variation in organ position and movement (except
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those induced by breathing, which will be discussed later) and patient set-up error
[31]. The standard deviations of these random error components are denoted by σi
and quadrature addition of these components gives the combined standard deviation
σ.
Van Herk and co-workers established a margin recipe to account for systematic
(treatment preparation) errors and random (treatment delivery) errors separately.
They mathematically modelled the blurring of the dose distribution as a consequence
of the random errors as a convolution. In their work, they proposed a way to
calculate the margin needed to compensate both for the random errors and for
the systematic errors that generally cause a shift in the dose distribution. They
calculated the probability that the cumulative dose to the CTV exceeds a given value
for a population of patients and plotted the result as a dose–population histogram.
Van Herk and co-workers also modeled the CTV with the presence of systematic
errors as an extended CTV. Then, by reversing the procedure for computing dose–
population histograms for this extended CTV, they established a way to derive
treatment margins.[21]
The first step is to define an objective for the treatment. This means that a
threshold dose parameter is defined for a specified probability level, i.e. a fraction
of patients. This kind of an objective could be for example that the minimum dose
to the CTV must be at least 95% of the prescribed dose for 90% of the patient
population. [21]
The second step is to choose the volume C (for example an ellipsoid) representing
the distribution of the preparation (systematic) errors so that 90% of the systematic
errors fall into this ellipsoid. An ellipsoid with a vector radius of αΣ is chosen. Here
Σ is the combined standard deviation of the treatment preparation errors and it
is a vector because the standard deviations may be different in different directions
x, y and z. This volume C is a geometrical concept with which it is possible to
construct the margin to be added to CTV to take the systematic variation into
account. This volume, named extended CTV by Van Herk and colleagues [21] is
called the systematic target volume (STV) in this text.
The next step is to ensure that even with random delivery errors the set dose
threshold is fulfilled. Without treatment delivery errors, the chosen isodose surface
Dplanned (e.g. 95%) must be aligned with the STV. The extra margin to account
for treatment delivery errors is the distance between the planned and actual 95%
isodose surfaces Dplanned and Dblurred, respectively. This distance can be calculated
by using the 50% isodose surface, which does not change in position as a result
of blurring, as a reference [21]. The distance can then be expressed as βσ − βσp,
where βσ is the distance between the 95% and 50% isodose surfaces of Dblurred,
and βσp is the distance between the 95% and 50% isodose surfaces of Dplanned. σp
is the standard deviation describing the width of the penumbra and σ is the total
standard deviation of all treatment delivery variations including the penumbra. [21]
The total PTV margin
mPTV = αΣ + βσ − βσp, (2)
where mPTV, Σ and σ are vectors, which allows the usage of this equation to cal-
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culate non-isotropic margins. In this formula, the specific value for α for 90% confi-
dence in 3D is 2.5 [21]. This comes from the standard deviation of the 3D Gaussian
distribution. The numerical value of β is different for each beam configuration in a
treatment plan [32]. There are sources of error, which are recommended to be added
to the total margin linearly and not by quadratic addition. These errors still need
to be added to this formula. The PTV margin now becomes
mPTV = 2.5Σ + a+ b + β (σ − σp) , (3)
where a is the treatment planning system beam algorithm error and b is the breath-
ing positional error. The probability distribution for the position of a target moving
under the influence of breathing is not a Gaussian distribution [15]. The target
spends most of the time around either of the two extreme positions, the inhalation
and exhalation points and hence the probability distribution of the target has two
peaks rising asymptotically at these extremes [32]. Any margin less than b will lead
to target underdosage. The most practical approach to take the breathing-induced
uncertainty of the target position into account is linear combination so that a margin
of width b is added to both directions [15].
If the total error for each treatment fraction can be measured, one can calculate
the total systematic error standard deviation Σ and the total random error standard
deviation σ. It is possible to estimate for example the effect of image guidance
because the initial patient set-up to the skin markers is the same with and without
image guidance. In this specific application, the amount of error is quantified by
measuring the translations made in order to correct the errors in the initial set-up
[16].
Table 1: Estimating the SD of random and systematic errors based on measurements
in a population of patients. The numbers in this table could be the shifts of the
patient (mm) in the left–right direction determined by comparing portal images
taken before treatment to the DDRs reconstructed based on the planning CT. For
each patient, the mean and SD of measurements of several fractions is determined.
An estimate of the errors for a population of patients is calculated by different
combinations of these values. Table modified from Ref. 16.
Patient 1 Patient 2 Patient 3 Patient 4
Day 1 2 4 1 3
Day 2 1 –2 –1 –3
Day 3 1 2 2 –2
Day 4 1 0 2 1
Mean = M = 0.75
Mean 1.25 1 1 –0.25 SD = Σ = 0.68
SD 0.50 2.58 1.41 2.75 RMS = σ = 2.03
Van Herk et al. [16] describe the way to calculate the magnitude of the systematic
and random errors (Table 1). By averaging all the mean shifts for the individual
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patients, one obtains overall mean M, which is the group systematic error. This error
is expected to be small and the small deviations from zero are due to the imprecision
of in the equipment (lasers) and procedure. By calculating the standard deviation
of the individual means, one gets Σ, an estimator of the systematic error standard
deviation. The individual standard deviations give the standard deviation of the
random error for each individual patient. The random error standard deviation σ
is the group mean of the individual standard deviations, determined by calculating
their root mean square. [16]
The photon penumbra width parameter σp can be measured by division of the
distance between the 10% and 90% isodose level of a single beam at a typical treat-
ment depth by 2.56 [15]. The penumbra dose is assumed to be described by the
error function [15].
2.2 Accuracy of radiotherapy in treatment preparation – sys-
tematic errors
There are both geometric and dosimetric error sources in the treatment preparation
as well as treatment delivery. In the next sections the whole radiation therapy
treatment preparation process is briefly described, with special emphasis on the
possible sources of error during each phase. Accuracy in the treatment preparation
is essential, since the errors originating in treatment preparation are systematic and
hence have a great effect.
2.2.1 Treatment simulation
Generally, the error sources in the treatment simulation emerge from three sources:
the patient set-up, the geometric imaging error and the image quality. The patient
set-up during the treatment is based on marks on the skin that are tattooed during
the treatment planning CT session. Therefore, the motion of the skin with respect
to the internal anatomy limits the set-up accuracy [15; 16; 20]. Skin mobility during
treatment delivery causes an error, but this error varies randomly from day to day.
Rather than in a position representative for the situation in treatment, the skin
might be in an extreme position during the CT simulation, which causes systematic
error during the treatment. The reproducibility of the patient positioning can be
improved by immobilization methods, but because of the skin mobility, the set-up
accuracy is never perfect [16].
The geometric imaging error in the CT includes the geometric uncertainties in
the imaging room such as the alignment of the lasers and the indication of the couch
position [15]. There is also uncertainty in the placing of the tattoos marking the
location of the isocentre. These marks can be erroneous if the patient has moved
between the time points of imaging and tattooing. This is especially detrimental if
the body outline is rapidly changing at the place of the isocentre, e.g. the lateral lo-
cation at the patient’s cheek. Since the tattooing is done by hand, it is naturally not
completely certain whether the markings exactly hit the locations of the positioning
laser projections on the skin.
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Computerized tomography is based on producing a 3D image set based on mul-
tiple two-dimensional projections aqcuired from different directions. The subject is
scanned being divided to thin axial slices and each slice is divided into a matrix of
3-dimensional rectangular boxes called voxels [33]. The image is reconstructed by
determining how much attenuation of the narrow x-ray beam occurs in each voxel of
the reconstruction matrix and the attenuation values are represented as gray levels.
At present, an iterative reconstruction algorithm is mostly used to solve the inverse
problem of reconstructing the geometry of the slice based on the projections from
different angles [34].
CT image quality is a potential source of errors. CT image quality is described
in terms of contrast, spatial resolution, image noise and artifacts [35]. With CT it
is possible to visualize structures with low contrast and discriminate with different
tissues with similar densities [35]. If a poor quality CT scan leads to misinterpre-
tation of the GTV, the error has an effect on the treatment plan and finally to the
treatment and thereby can have a great effect on the outcome. In addition to the
delineation, the image is used in the dose calculation. An artifact is any systematic
discrepancy between the CT numbers in the reconstructed image and the real at-
tenuation coefficients of the object [36]. In the case that this kind of discrepancies
exists in the image, the image quality has the potential to affect the dose calculation.
Organ motion causes error both during treatment simulation and treatment. CT
image represents just one arbitrary position that the moving organ had at the time
of the imaging and systematically affects the dose distribution [12; 16; 20; 21]. Organ
motion can also have an effect on the image quality.
2.2.2 Accuracy in radiation production
In this chapter the radiation production and the associated geometric errors are
described. The dosimetric errors are reviewed in the chapter about treatment plan-
ning. The errors in the linear accelerator geometry are likely to remain relatively
stable over the course of the treatment and thus result in a systematic error [15].
The linear accelerator is a device that accelerates electrons along a linear tract
with the radio frequency (RF) power produced by a magnetron or a klystron. The
electrons are boiled out of a hot cathode and accelerated to energy of up to 25
MeV. When producing photons, these electrons are made to hit a tungsten target
where a portion of their energy transforms into bremsstrahlung, that is, photons.
When producing electrons, the target is moved out of the way, letting the electrons
pass (Figure 5). More detailed description of the electron acceleration and beam
production is available in [13].
Both photon and electron beam shaping into a useful treatment beam happens
in the radiation head of the linear accelerator. The beam characteristics are strongly
influenced by the treatment head design [13]. There are a number of beam-shaping,
localizing and monitoring devices in the radiation head. These include the bend-
ing magnet if used, the fixed primary collimator, the x-ray target, flattening filter,
scattering foils for electron treatments, moveable secondary collimator jaws and the
multileaf collimator. The primary collimator collimates the beam that then goes
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Figure 5: Schematic drawing of a linear accelerator treatment head. (A) Photon
beam therapy. The X-ray target has been moved on the way of the beam and
the carrousel is in a position where the beam goes through the flattening filter. The
beam is formed with the secondary collimators and the multi-leaf collimator (MLC).
(B) Electron beam therapy. The X-ray target has been moved out of the way of the
beam and the carrousel is in a position where the beam goes through the scattering
foil. The field is formed close to the patient with a block attached to the electron
applicator. Figure modified from Ref. 13.
17
through the flattening filter or scattering foil (photon and electron treatments, re-
spectively. The secondary collimator and the multileaf collimator perform the final
beam shaping in photon treatments and in electron treatments, the beam shaping
is done close to the patient with specially designed electron blocks. In the follow-
ing, the different beam shaping procedures in the treatment head are reviewed with
special emphasis on accuracy and error sources.
Magnets are used for focusing and tuning the electron beam as well as changing
its direction in the case that the electron accelerator guide is not in line with the
gantry. The accelerated electron beam is composed of electrons which all have
different energies, are displaced radially and have their trajectories in different angles
from the mean. The changes in mean energy, trajectory angle or displacements from
the mean axis cause distortions in flatness of the electron beams.
If electrons are used, the beam is evened and spread to the required width with
scattering foils. The photon beam needs to be flattened with a flattening filter in
order to get an even beam to the patient. The braking radiation beam from the
target has fluence, energy and angular distributions. The flattening filter effect
depends on the distance and the shape of the filter is chosen so that an even dose is
achieved at about 10 cm depth [13]. Angular or lateral displacements of the beam
have an effect on the flattening result and it is thereby essential that the beam
remains rigidly centred on the axis of the flattening filter.
There are two separate questions to be asked in estimating error in isocentre
location. Firstly, one should find out if the radiation field isocentre of the treatment
machine really is where it is thought to be. The place of the isocentre is affected by
the mechanical properties of the treatment machine. The second question is whether
the patient positioning laser indication shows this same precise isocentre.
The couch mechanical properties can cause geometric error, couch sagging [17].
It means that the couch position and angle somehow depend on the weight that is
placed on the couch, i.e. the couch is not truly rigid but bends, producing distortions
to the patient’s body outline and to the position of the organs relative to the bones.
Couch sag can be corrected for by imaging and with current treatment couches it
is a problem mostly with heavy patients. There can be also gantry sagging, which
must also be accounted for in the treatment planning.
The tolerance for each of the linear accelerator geometry error components men-
tioned above is defined by the national regulations and the clinic specific protocols.
The mechanical properties of the linear accelerator are monitored regularly. The
position indicators such as the lasers, light fields and the optical distance indicator
are tested every day [37]. In Helsinki University Central Hospital, the field size is
tested every month and the isocentre position is checked every 6 months. The gantry
and collimator angle indication and the straightness and movements of the couch
are checked by technicians every 4 months and by the physicists every 6 months
[37].
The amount and quality of the produced radiation is monitored with an ion-
ization chamber sampling the treatment beam. The units of the monitor chamber
for the amount of radiation, the monitor units, are used in the treatment planning
process to describe the actual dose to be given to the patient. The number of mon-
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itor units needed to be produced in order to achieve a dose of one gray needs to
be measured for each linear accelerator and each photon and electron energy. The
properties of the produced beam are measured and used for the configuration of
the machine to the treatment planning system and thus also need to be monitored
regularly. In Helsinki University Central Hospital, the relative dose is measured 2
times a week. The field characteristics are measured more profoundly at least every
6 months and always when there is reason to suspect that they have changed [37].
The absolute dose produced with the accelerator may have a maximum ±2% devi-
ation from the value that has been configured to the treatment planning system for
the dose calculations [37]. The dosimetric errors are addressed in the chapter about
treatment planning.
2.2.3 Target definition
Delineation of the GTV involves numerous geometric uncertainties and can be the
greatest single source of geometric uncertainty in the treatment process [15]. Delin-
eation errors are systematic for each individual patient, but have a stochastic nature
over the whole population and thus cannot be estimated in advance for a single pa-
tient [20; 21]. The limited resolution of the imaging modalities causes uncertainty
to the target definition. Different observers have been found to delineate the same
volume differently (interobserver variability) and even the same observer never de-
lineates the same volume exactly the same way when asked to repeat the delineation
(intraobserver variability) [38; 39]. Even the imaging modality used has an effect
[40]. It is hard to quantify the actual delineation error as there is no absolute truth
available [15]. The differences between the institution guidelines according to the
target volume formation have a significant effect on the result [19].
CTV to PTV margins needed to account for the uncertainties in patient posi-
tioning and movement, as well as alignment of the therapeutic beams, might depend
on the irradiation technique selected [41; 42]. The more complex the field set-up,
the steeper the dose gradients and thus, the more sensitive the plan is to set-up
uncertainties [42].
2.2.4 Treatment planning and dose calculation
Treatment planning system error consists of three different components. The first
is the possible error in the exact orientation of the image when the CT image set
is transferred to the treatment planning system. The second component producing
uncertainty is the automatic algorithm for forming the PTV by adding margins to
the CTV. The third TPS error component is the error in drawing templates used
for positioning and producing shield blocks for electron treatments. Another error
of the treatment planning system, the photon beam algorithm error is present when
the planned penumbra is too wide or too narrow compared to that of the measured
dose distribution. This error causing either systematic underdosage or overdosage
at the field border can be compensated for by the parameter a in Equation (3). [15]
Always when a new linear accelerator is acquired to the hospital, its individual
MU–dose correspondence information is measured. This information is used to
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configure a model, i.e. a quantitative machine [43]. In the treatment planning,
the amount of monitor units needed to produce a specific dose distribution can
then be calculated using this virtual treatment machine. Follow-up measurements
need to be done periodically and if there are deviations from the original values,
the model needs to be reconfigured [43]. The error due to machine configuration
remains systematic for all patients.
Every model is a simplification and thus, the dose produced is not exactly the
dose planned. According to the Finnish Radiation and Nuclear Safety Authority
(Säteilyturvakeskus, STUK), there can be maximum 3% deviation in the reference
point dose and 5% / 5 mm in target volume dose between the calculated and mea-
sured dose [44]. These are maximum deviations, but the aim is to maximize the
accuracy.
2.3 Precision of radiotherapy in treatment delivery – random
errors
The treatment delivery phase covers the whole treatment after the treatment prepa-
ration phase, essentially the patient set-up and radiotherapy on each treatment
fraction. As mentioned previously, the random errors occurring in the treatment
delivery impact the treatment differently each time and have a blurring effect on the
dose distribution. In the next chapters the error sources inherent to the treatment
delivery are discussed.
2.3.1 Positional imprecisions in treatment delivery
Treatment delivery is trying to mimic every aspect of the CT simulation situation
as well as possible. The patient set-up should be reproduced as precisely as possible
on each fraction of the treatment. The extent of gantry and table flexibility should
be measured and compared between the CT and the treatment machine [15] and
standardized if possible. Standardization is important also in the case of laser light
systems, where variations in thickness of laser lights can cause significant uncertainty
[15]. The immobilization devices used for the set-up should be checked regularly in
order to maintain the geometric accuracy throughout the treatment [15].
In addition to deviations in these external factors, also changes in patient’s clin-
ical variables such as the bladder filling or weight can cause imprecision and should
be evaluated [15]. Organ motion is an important source of uncertainty, in the case of
the bladder even the main source of error [6; 20; 45–47]. The motion of the bladder
will be discussed in more detail later in this text.
Organ motion can be divided into three categories: motion of the organs related
to patient position changes, organ motion which occurs in-between fractions (in-
terfraction), and motion that occurs during fractions (intrafraction) [12]. Position-
related organ motion arises if the patient position during planning scan is different
than during treatment [12].
Interfraction organ motion occurs when the position of the CTV changes from
day to day. It is mainly associated with organs that are part of or close to the
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digestive system, but can also be caused by changes in the condition of the patient,
such as weight loss or gain [12]. Intrafraction motion is organ motion that occurs
during the radiation fraction of the patient. In the case of the bladder, intrafraction
motion causing geometric uncertainty arises from bladder and rectum filling and
bowel gas movement. An additional source of uncertainty arises from intrafraction
motion in the case that the radiation field includes a part of the intestinal system,
where the realized dose can be influenced by the motion.
Organ motion can be tried to be restricted by using different protocols which aim
to achieve a reproducible situation for the organ. If this is not enough to solve the
problem, there are techniques such as gated RT, breath-hold techniques and tumour
tracking than are used to sync the irradiation according to the motion [12]. When
none of these techniques are available and also to compensate for the remaining
positional uncertainty, the extent of the motion must be determined and margins
can then be set to account for the organ motion.
2.3.2 CBCT image quality
Cone-beam computed tomography is an imaging method with which one can have
3-dimensional images of the patient at the time of the treatment. The equipment
used for CBCT consists of an x-ray tube mounted on a retractable arm and an
x-ray detector mounted opposite the tube and can be integrated with a medical
linear accelerator. Cone-beam CT operates on the same principle as conventional
fan-beam CT, except for that an entire volumetric image is acquired through a single
rotation of the source and detector. This is possible, because a 2D-detector is used
as opposed to the 1D-detectors used in conventional CT [48].
In the pelvic area, soft-tissue motion and deformation including gas pocket move-
ment in the rectum occur regularly and result in severe imaging artifacts that may
make the identification of soft-tissue boundaries extremely difficult [49]. These ar-
tifacts are even more severe than in conventional CT [50]. This is explained by the
time needed for the imaging with each method. In conventional CT, each rotation
of the scan can be completed within 1 second or less and organ and tumour motion
is relatively small during this time. In a CBCT scan, however, the rotation speed
of the gantry restrains the speed of the scanning and the acquisition of a full 360
degrees projection scan typically lasts for 1 min [50].
The treatment can be endangered by insufficient image quality of the treatment
image guidance if the images are misinterpreted and for example a wrong transla-
tion is made causing treatment volume miss. It is possible to use different body
restraints and breath-hold protocols to restrict the motion [50]. Smitsmans and
co-workers introduced a dietary protocol to reduce the amount of moving gas and
had a significant effect on the achieved CBCT image quality [51]. Motion of bowel
gas during CBCT acquisition has been described to be particularly detrimental for
image quality [49]. The CBCT image quality can be thought to indirectly indicate
intrafraction (short term) and interfraction motion of tissues [51].
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2.4 Radiotherapy of the urinary bladder
The bladder cancer is in Finland the most common cancer of the urinary tract and
the fourth most common cancer type in males [52]. There are multiple different
types of bladder cancer, the majority of which are restricted to the inner surface of
the bladder and have a good prognosis [52]. These patients are mostly treated with
bladder-sparing approaches such as transurethral resection. Roughly 25% of the
bladder cancers has infiltrated to the muscular wall of the bladder when diagnosized
and about 5–10% of these patients also have a metastasized cancer [52]. The patients
with muscle-invasive bladder cancer are treated with radical surgery or radiotherapy,
but the optimal choice of therapy is a topic of debate [45; 53]. Even with treatment,
roughly half of the patients suffering from muscle invasive bladder cancer die in 5
years [52]. This text will concentrate on the treatment of muscle invasive bladder
cancer.
The treatment of the muscle invasive bladder cancer varies based on how widely
spread the disease is and the overall condition of the patient [52]. The primary
method for treatment of muscle invasive bladder cancer has traditionally been radi-
cal cystectomy where the whole organ is surgically removed [45; 54]. Contraindica-
tions for cystectomy are usual among the high-aged patient population [45] and the
possibility to remain bladder function has evoked interest to the bladder preserv-
ing treatment methods. Combined with other treatment modalities as the principal
component of local treatment, radiotherapy has the potential for being an organ-
preserving alternative [45; 55]. Muren et al. [45] and Milosevic et al. [56] provide a
review of these combined-modality studies.
2.4.1 The challenges in the treatment
The bladder base is anchored at the level of the pelvic floor, but several surround-
ing structures affect its size and shape [57]. These structures include the anterior
abdominal wall, small bowel, prostate, rectum and uterus. Also the degree of filling
of the bladder itself affects the bladder shape and size [58] and it can even be the
dominant source of bladder motion [47].
Several studies have found the bladder motion to be the most significant at the
cranial and posterior part of the urinary bladder [20; 59; 60]. Meijer et al. believed
the reason to be that in these areas the bladder can move freely without obstruction
with the rectum and the sigmoid [20]. Meijer and co-workers observed the smallest
variation in the ventral–caudal side of the bladder, where the bladder abuts on the
symphysis [20].
McBain et al studied maximal bladder wall displacements in bladder cancer
patients with cine-MRI and found them to be larger (median 27 mm, range 6–
58 mm) and more variable in direction than those of the healthy controls (median
5.5 mm, range 0–7 mm) [47]. The tumour might change the normal physiological
stretch pattern of the bladder [61]. McBain and colleagues suggested that there
might be a tendency for bladder expansion occurring away from the tumour-bearing
wall [47]. Muren et al. studied bladder motion during RT by means of weekly CT
scans [6]. Patients were instructed to void before the treatment / repeat scanning
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sessions. Bladder displacements as large as 29–36 mm were observed at the superior,
left, anterior and posterior side of the bladder and the bladder displacements were
in general largest at these four sides [6]. To give an example of the scale of bladder
displacements possible during RT, Table 2 taken from Muren and colleagues’ study
is presented here.
Table 2: Summary of urinary bladder displacements observed in repeat CT scans.
Table modified from Ref. 6.
Inferior Superior Left Right Anterior Posterior
Overall maximum (mm) 15 32 31 15 36 29
No. of scans
with displacements ≤ 10 mm 6 29 14 5 24 16
No. of patients with at least one
scan with displacements ≤ 10 mm 5 9 7 3 8 8
No. of scans
with displacements ≤ 15 mm 0 12 4 0 12 2
No. of patients with at least one
scan with displacements ≤ 15 mm 0 5 2 0 4 2
No. of scans
scan with displacements ≤ 20 mm 0 7 4 0 6 1
No. of patients with at least one
scan with displacements ≤ 20 mm 0 4 2 0 3 1
There are several technical challenges in accurate RT delivery to the bladder
tumour [3; 4]. The bladder is a hollow, mobile organ whose position and volume
vary significantly between different treatment sessions [3; 12; 45; 47; 57; 62; 63].
There is also a variable but continuous flow of urine into the bladder [45] which
can cause intra-fraction motion. Tuomikoski et al. reported the observed maximal
growth in the bladder dimensions during 15 minutes to be less than 10 mm in all
orthogonal directions [61]. It is likely that the bladder shape in the planning CT
scan differs from that during the course of the treatment resulting in a significant
systematic error [62; 64].
An interesting question is whether the bladder movement, posing a challenge
to bladder RT, could be controlled for or restricted. Several strategies to restrict
the individual variations in bladder volume have been studied [4; 5; 46; 58; 65].
These strategies aim at making the situation of the bladder in the treatment as
reproducible and controlled as possible, achieving a more successful treatment and
possibly being able to use smaller margins. These strategies include for example
different voiding or dietary protocols but also more invasive methods to restrict the
bladder movement. The strategies for restricting the bladder volume variability are
reviewed in this chapter.
Fluid intake restriction protocols have been suggested to control the intra-fraction
volume change [46]. Muren et al. attempted to control the bladder volume by re-
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stricting fluid intake prior to the treatment [65]. They reported that this fluid intake
protocol failed to give any reduction in the margins required for the treatment [65].
Void protocols have also been suggested. Treating the bladder while empty
minimizes the radiation field size. Further rationale for instructing the patient to
void before treatment is to be able to reproduce the bladder volume as well as
possible during the course of the treatment [46]. The empty bladder also increases
patient comfort [46], which helps in maintaining the treatment position during the
whole treatment fraction.
Instructing the patient to void might not be a magical solution. Although pa-
tients were asked to empty their bladder, significant variations in volume, up to
20–25%, remain [4; 5]. Bladder cancer patients have different degrees of bladder
wall invasion that may impair the contraction and emptying of the bladder [4]. The
tumour can significantly affect the ability to consistently empty the bladder. The
bladder wall fixation due to the tumour may also affect the filling and emptying
patterns of the bladder [4]. Bladder cancer typically occurs in the elderly, whose
bladder function may be deteriorated [66–68].
One option would be to control the fluid volume in the bladder by using a
Foley catheter [4]. This way it would be possible to insert an identical fluid volume
to the bladder for RT planning and before each RT fraction. There are, however,
multiple drawbacks such as bladder trauma, patient discomfort and possible bladder
infections [4].
To stabilize the bladder volume and the shape of the bladder, Miralbell et al
tested a urinary catheter balloon [58]. The procedure was unpleasant and produced
painful bladder spasms in all of the eight patients [58]. Even with this procedure,
bladder reproducibility accuracy was not perfect [58].
Especially in partial bladder irradiation, the image quality is a restricting issue
[61]. Without adequate imaging information, one might risk missing the target [61].
Bladder visualization can be aided with different kinds of markers, such fiducial
markers as well as different radio-opaque contrast media. With these markers it is
possible to track the bladder movement [4]. The efficacy of the tracking depends
on the ability of the markers to reliably and correctly represent the target volume
position and whether they remain visible during the whole course of the treatment
[69].
Soft-tissue visualization ability of the imaging method affects how well the changes
in bladder shape and volume can be taken into account. Especially in partial blad-
der irradiation, tumour delineation in the CT image is problematic since the bladder
tumour has often been resected before the RT treatment or the patient has received
neoadjuvant chemotherapy and the visibility of the remaining scar tissue in CT is
poor [54; 61; 70]. A CT scan might underestimate the mucosal borders of the tu-
mour or overestimate them in the case that there is oedema following transurethral
resection of the tumour [71]. As the markers are implanted in cystoscopy, they
would allow marking the tumour borders and also aid the image registration process
[61]. Without contrast agents, the tumour cannot be reliably detected in CBCT im-
ages [61]. On the other hand cystoscopy cannot show spread beyond the submucosa
[4; 71].
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Fiducial markers, such as titanium or gold seeds implanted in the mucosa of the
bladder have been investigated [3; 24; 71]. Fiducial markers do not increase bladder
toxicity due to standard cystoscopy [24] and are also voided without symptoms
[3; 71]. Nevertheless, the procedure is invasive and associated with risks of bleeding,
infection and bladder perforation [4]. Certain lesions may not be accessible with
marker seeds [4]. It is also uncertain how many seeds are needed to accurately
account for bladder wall movement [4]. As the implantation is based on cystoscopy,
microscopic lesions cannot be visualized at all [4]. The accuracy of the procedure
naturally relies on the physicians’ skill [4]. In the case of the bladder, seed dropout
is a possible drawback [71].
In addition to the fiducial markers, also radio-opaque contrast media have been
suggested for radiotherapy of the bladder. Lipiodol R© is a poppyseed oil that can
act as a contrast agent [61]. Small drops of Lipiodol R© are injected into the bladder
wall through a flexible cystoscope during cystoscopy to mark the borders of tumour
[61]. Several groups have reported using Lipiodol R© for marking the target volume
[25; 61; 69].
2.4.2 Conventional radiotherapy
The standard method for radiotherapy for muscle invading bladder cancer has tra-
ditionally been irradiation of the whole bladder and tumour with a 2–3-cm margin
to a dose of 60–66 Gy [53; 62]. The set-up precision is verified with imaging, but
since the soft tissues are poorly visualized with two-dimensional planar imaging, one
cannot see the exact position or size of the bladder. Bladder movement cannot be
controlled by external fixation devices used in the set-up and thus, no matter how
well the bony anatomy agrees with the planning position, large margins have to be
used in order to take the bladder movements into account. The clinical target vol-
ume is the whole bladder and visible tumour with large isotropic margins creating
the planning target volume [46].
The total dose in the conventional radiotherapy treatment of the bladder is rel-
atively low compared with doses used in other cancers such as prostate cancer, lung
cancer and head and neck cancers [7]. As there is evidence of a dose–response rela-
tionship [7; 72], i.e. the higher the dose the better the outcome, dose escalation has
been suggested to be a reasonable strategy to improve the radiotherapy of invasive
bladder cancer [7]. Reduction of the margin could allow an escalation of the dose,
but usage of an inadequate margin could lead to a large dose deviation inside the
treatment target due to positional variation in the treatment process.
There are two key problems in the traditional approach [47]. The first is that the
irradiated volume includes a large volume of normal tissue, especially the bladder
itself and the small bowel [54]. The large irradiated normal tissue volume leads
to high normal tissue toxicity and inhibits dose escalation [47; 54]. Radical radio-
therapy of the bladder can cause serious side effects [20], both acute and long-term
[59; 73]. These complications include bladder function decrease, cystitis, diarrhea,
obstruction or constriction, fistula or perforation and ulceration, and can lead to
undesired treatment interruptions [54; 59; 74]. Some complications may also require
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surgery or even lead to the patient’s death [59]. The second problem is that the
approach may still be inadequate to account for bladder motion in up to 65% of the
patients [62; 63].
More conformal irradiation techniques are based on the thought that the focusing
the dose distribution to the target will be beneficial in two alternative ways. More
focused radiation distribution is either less damaging to the normal tissue if main-
taining the same prescription dose or improved local control may be obtained with
equivalent normal tissue side effects if the prescription dose is increased [7; 71; 72].
Increasing the treatment dose and concomitant chemotherapy might be options to
improve local control in the case of the bladder cancer [7; 71], provided that the
normal tissue irradiation can be reduced. The increase in normal tissue sparing
might also enable evolution of hyperfractionated treatment protocols that would
be suitable for those patients who are not able to tolerate conventional treatment
schedule lasting 6.5 weeks [9].
By conformal radiation therapy one implies to techniques in which the border of
a certain reference isodose surface, e.g. 95% is matched to conform closely to the
surface of the target volume [72]. Higher conformity of the dose requires imaging of
the soft-tissue target, which is only possible with 3D imaging methods.
3-dimensional imaging at the time of the treatment allows visualization of the
bladder. The information of the position and size of the bladder helps to elimi-
nate the possibility for misses in the treatment, as one can account for the possible
misalignment of the beams by making some correcting translations before the treat-
ment. If the bladder is too big to fit into the treatment volume, the patient can be
asked to void their bladder. Thus, ability to 3D-visualization adds to the probability
of successful treatment and the reduction of set-up margins helps reduce the volume
treated to a high dose [65; 75; 76]. Nevertheless, without being able to modify the
treatment volume based on the imaging, large internal margins are still needed when
treating the mobile bladder [6].
The 3D-imaging, however, offers much greater potential than merely reposition-
ing the patient and avoidance of misses. If one has the ability to adapt the size
of the treatment volume to the bladder size, one can reduce the irradiated volume
thus avoiding the resulting unnecessary complications. Reduction of the irradiated
volume might make dose escalation possible. This can be achieved with adaptive
radiation therapy. In 2004, Muren et al. estimated the bladder to be one of the
sites with the greatest potential benefit from equipment that is designed for local-
ization of the tumour daily before the treatment [45]. Adaptive radiation therapy of
the bladder has been one of the greatest improvements enabled by improved target
localization. The assessment of Muren and colleagues could be judged to have been
right. The next chapter reviews adaptive radiation therapy studies and the benefits
achieved with adaptive treatment.
2.4.3 Adaptive radiotherapy
Adaptive radiotherapy (ART) treatment was first suggested by Yan [8]. The idea was
to adapt the margin and the treatment dose individually for each individual patient
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instead of using population-based margins and treatment doses. In the article of
Yan, the adaptive prostate cancer treatment serves as an example of the application
of the process [8]. Yan suggests defining the individual margins and treatment doses
based on information gathered with electronic portal imaging and CT scans during
the first a few fractions. This technique to create a single adaptive treatment plan
for the rest of the treatment based on the imaging information acquired during the
first fractions is called oﬄine adaptive radiotherapy [9]. However, Yan also pinpoints
that this process can be repeated if necessary during the entire treatment course,
suggesting also the possibility of daily online adaptation. In online ART, the target
volume is adapted before the treatment to represent the situation of the particular
day, based on the imaging information of the treatment machine.
One way to implement online ART is that a library of pre-planned treatment
plans is first created and the daily treatment plan is then selected from this library
[9]. The ways to form this library and the ideas behind the methods differ. Since
there are only a limited number of studies about bladder ART, the most essential
studies of adaptive bladder radiotherapy, both oﬄine and online, are reviewed in
the following. It is easy to summarize the results of the studies: With ART it is
possible to achieve improved CTV coverage [7; 40; 77] and / or reduction in the
normal tissue (especially small bowel) irradiation [7; 9; 10; 61; 78–81]. Also the dose
conformity can be higher with ART [40; 70].
The different ART protocols used are described in the text and the results as well
as some elementary information of the studies are described in Table 3. As well as
reviewing different adaptive radiation therapy protocols that have been suggested,
the pros and cons in these methods are quickly reviewed and the different ideas
behind the methods are compared. It can easily be seen that no ultimately superior
method for adaptive radiation therapy has been invented yet, but all the suggested
methods have their justifications as well as their downsides.
Oﬄine adaptive radiotherapy is relatively simple to implement but it does not
correct for random errors. Oﬄine adaptive radiotherapy strategies have been used
for both partial bladder irradiation and whole bladder irradiation [7; 40]. In oﬄine
ART, there is adaptation to the individual scale of bladder movements but not to
the individual days’ positional situation of the bladder.
Pos et al. evaluated the feasibility of oﬄine adaptive radiotherapy with a partial
bladder treatment [7]. They treated the bladder tumour plus a 2-cm margin and
acquired five daily CT scans immediately before or after treatment. Based on the
tumour volumes visible in these images, Pos and colleagues constructed a volume
that encompassed all the GTVs visible in these scans, PTVART was constructed
by expanding this GTVART with a 1-cm margin. Starting from the first week, the
patients were treated to this PTVART.
Foroudi and colleagues evaluated an oﬄine adaptive protocol in practice and
modeled an online adaptive protocol to be able to compare the CTV coverage and
the dose conformity index between the conventional RT treatment and these optional
adaptive methods [40]. In the oﬄine process, five CBCT scans were acquired during
the first week of treatment and the average of these volumes was expanded with a
1.5-cm margin to form the oﬄine adaptive PTV. This volume was used for treatment
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Table 3: A summary of the bladder adaptive radiotherapy studies and their key
results. ART = adaptive radiotherapy, Ref. = Reference, S = Simulation, T =
Treatment, WBI = whole bladder irradiation, PBI = partial bladder irradiation,
SIB = simultaneously integrated boost.
Study Ref. N S / WBI / Online / Key results
T PBI Oﬄine compared to non-adaptive
Burridge et al. [78] 20 S WBI Online Small (31 ± 23 cm3) sparing
2006 of irradiated bowel volume
Pos et al. [7] 21 T PBI Oﬄine Better CTV coverage,
2006 40% reduction
of treatment volumes
Foroudi et al. [40] 5 T WBI Oﬄine Improved CTV coverage
2009 in 2/5 patients,
higher conformity index
S Online Yet better dose coverage
than the oﬄine method
Vestergaard et al. [10] 10 S WBI Online Reduction of volume
2010 receiving high dose 33–34%
Foroudi et al. [79] 27 T WBI Online 29% reduction in V(normal
2011 tissue receiving ≤ 45 Gy)
Lalondrelle et al. [77] 15 S WBI Online Fewer target misses
2011
Murthy et al. [82] 10 T WBI + Online Plan-of-the-day technique
2011 SIB feasible for ART
Tuomikoski et al. [9] 5 T WBI Online On average 66 ± 36 cm3
2011 reduction in bowel
volume receiving ≥ 45 Gy
Meijer et al. [70] 20 T WBI + Online Conformal dose distribution,
2012 SIB Lipiodol R© facilitated
image guidance
Tuomikoski et al. [61] 5 T PBI Online V(healthy bladder) receiving
2013 high doses smaller when
treated with full bladder
Vestergaard et al. [80] 7 S WBI Online V(tissue receiving ≥ 95% of
2013 treatment dose) reduced
to ≥ 66% plan selection
/ 41% re-optimization
Vestergaard et al. [81] 20 T WBI Online Reduction in PTV volumes,
2014 mean volume ratio of
course-averaged PTV
relative to non-adaptive
PTV 0.70
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from the third week onwards.
One could simplify that the more adaptive the method is, the more difficult and
time-consuming it is to implement. Online adaptive radiotherapy is a step to the
more adaptive direction from oﬄine methods and online re-optimization is a further
step onwards. However, although re-optimization has been successfully implemented
in simulation [80], it is challenging to adapt into the clinical use where there are time
constraints.
Burridge et al. were the first to model online adaptive radiotherapy for the blad-
der cancer [78]. They made conformal treatment plans using a four-field technique
and an isotropic CTV–PTV margin of 15 mm. They created two additional target
volumes by reducing the superior margin to 10 and 5 mm, which was estimated to
represent the magnitude of the changes in bladder dimensions. The online adaptive
method of Burridge and colleagues is easy to implement but since the reduction of
margin in the superior direction is not based on data of the actual individual patient,
there might be limitations to the method as the margins do not offer variability in
all directions [78].
In the study of Foroudi et al., the online adaptive method was retrospectively
simulated by creating three optional plans based on the first five CBCTs and the
planning CT image [40]. The smallest was based on the smallest CTV, the largest
on the union of all the CTVs of the images and the medium one on the average
CTV volume. These optional volumes were expanded with a 5-mm margin. There
were remaining five CBCT scans taken during the treatment for each patient and
these were used in the simulation. In a later study, Foroudi and co-workers reported
having used the online method for treating 27 patients [79].
Online adaptive radiotherapy requires daily imaging with the treatment machine,
which produces some radiation dose to the patient. Kron et al. [83] studied the
integral dose to the patient with the adaptive radiation therapy protocol of Foroudi
et al. [40]. The group found out that the increase in dose conformity resulted in
decreased overall radiation burden despite daily volumetric imaging [83]. Image
guidance did not cause an increase to the integral dose.
In the library planning approach, there are many varieties that are based on
capturing some of the bladder volume variation to the PTVs, but still employ dif-
ferent ideas. Lalondrelle et al. [77] and Tuomikoski et al. [9] employed an adaptive
strategy where the library of adaptive PTVs is formed based on several repeat scans
starting with a post-voiding planning CT scan, scanning every 15 minutes, with the
attempt to capture the individual bladder filling pattern of the patient. Lalondrelle
et al. examined bladder wall motion patterns during high-dose hypofractionated
bladder radiotherapy and validated an adaptive planning strategy to prevent geo-
graphic miss [77]. The strategy was named adaptive-predictive organ localization
(A-POLO). Tuomikoski et al. were able to reduce the dose to the intestinal cavity
with their strategy employing 4 post-void CTs [9]. The fractionation schedule was
conventional [9]. This method will be discussed in more detail later in this text,
since this method is compared to the method introduced by Vestergaard et al. [10]
in this study.
The strategies of Lalondrelle et al. [77] and Tuomikoski et al. [9] can be im-
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plemented from the first fraction on, and thus, Lalondrelle and co-workers mention
that the method be especially suited to hypofractionated radiotherapy in contrast
to the methods utilizing the information from the first fractions [77]. In the ap-
proaches based on recording the bladder filling pattern, it is crucial to have a right
combination of drinking and voiding protocols to be able to capture the maximal
filling of the bladder without patient discomfort. In the studies of Lalondrelle and
colleagues [77] as well as Tuomikoski and co-workers [9] there were cases where the
volume change during the planning repeat CT scans was inadequate to represent all
the filling states manifested during treatment.
In the study of Meijer et al [70] this challenge was addressed by first taking a
scan with the full bladder and then with an empty bladder and then interpolating
and extrapolating the needed alternatives to represent filling. However, it can be
argued that it is useful to have a more detailed modeling of geometrical changes in
the pelvic area than just two extreme conditions [61]. Also, making the patient go to
the toilet between the two scans might induce changes to the geometrical situation
in the pelvic area. To get the most descriptive and useful alternative plans when
starting with a postvoiding scan, it is useful to the aim to a more effective hydration
during the planning CT scans than during the treatment [61]. The time of image
acquisition and irradiation during the course of the treatment should not exceed the
time between the successive repeat planning scans [61].
In the protocol of Meijer et al., the library planning procedure was integrated
with image guidance using Lipiodol R© markers [70]. The whole bladder wall was
irradiated with a simultaneous boost to the bladder tumour or tumour bed [70]. The
GTV was marked with Lipiodol R© and two successive planning scans were acquired,
one with a full bladder and one with a voided bladder [70]. Six planning target
volumes were created by interpolation and extrapolation based on the empty and
full bladders [70].
An interesting question is whether to treat with an empty or full bladder. Usu-
ally, when the whole bladder is treated, it is beneficial to treat the patient with
an empty bladder, to reduce the irradiated volume and to increase patient comfort.
However, in partial bladder irradiation or when a simultaneously integrated boost
(SIB) is given, it treating with a full bladder might help identify the tumour and to
spare the rest of the bladder [82]. In their study, Tuomikoski et al. investigated the
sparing of the healthy part of the bladder during partial bladder irradiation with
Lipiodol R© contrast agent markings around the tumour [61]. They obtained CBCT
images every day before treatment, and almost weekly, also a post treatment scan
was acquired. They studied the impact of having a full or an empty bladder during
treatment to the sparing of the healthy parts of the bladder when treating only a
part of the bladder. Treatment with full bladder was found to spare the healthy
bladder. The authors used an ellipsoid model to predict the intrafractional changes
in the bladder volume, which worked with an acceptable accuracy [61].
In all of the different approaches utilizing the bladder filling pattern, there is a
concern whether the pelvic geometrical situation during the planning is representa-
tive of the patient anatomy during the treatment. Vestergaard et al. used CBCTs
from the first week of treatment [10; 80]. They estimated that this approach is more
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likely to capture the individual day-to-day pelvic organ motion patterns of the pa-
tient, when creating the library of adaptive plans [80]. It is more likely that there is
more variety in rectum filling and bowel loop configurations when images acquired
on a larger time scale are used. As mentioned previously, a similar idea was also
behind the method of Foroudi et al. [40; 79].
Vestergaard et al. compared three different online adaptive radiotherapy meth-
ods, which all were based on forming a library of three plans and selecting the daily
PTV of these alternative plans [10]. Method A utilized population-based margins
while methods B and C used the bladder as seen in the CBCT scans of the first
week. Method B did not require delineation of the bladder but method C did.
The authors calculated the total dose distributions based on the planning CT and
compared the ratios of the dose–volume histograms relative to the non-adaptive
radiotherapy between the methods.
In a later study by Vestergaard and co-workers [80], two adaptive radiotherapy
methods were compared. One of the methods was the same as method C in the
previous study [10] and was based on forming three alternative planning target
volumes based on the planning CT image and the CBCT-images of the first four
fractions. The other method took a step further from the methods based on a library
of plans and utilized daily re-optimization of the plan based on the CBCT-images
in the treatment [80]. Deformable image registration was used to propagate the
bladder contour from the planning CT to the CBCT-images. The method C is in
routine use in Aarhus and there has been a recent clinical trial showing decreased
planning target volume sizes [81]. The method is reviewed later in more detail, since
it is compared to the Helsinki method [9] in this study.
Using information acquired during many fractions has also its downsides. If
the method includes collecting imaging information during the first fractions, the
first fractions have to be treated to the full PTV volume, which adds to the normal
tissue dose even if it is lowered by the adaptive protocol. Vestergaard and colleagues
suggested a way to overcome this hurdle [80]. If a boost treatment is included, it can
be given before the actual treatment to be able to acquire the images without having
to use the conventional treatment plan during the first fractions [80]. However,
hypofractionated treatment is not possible with this kind of methods [77].
There are also approaches that use margins defined on a population basis [10] or
just approximated non-individually [78; 82]. In these methods there is no attempt
to track the individual bladder movements of the patient, and they are simple to
implement, but require that the scale of movements is correctly estimated.
Murthy et al. studied MVCT-guided plan-of-the-day radiotherapy [82]. The
planning CT and treatment were done with a full bladder, since the treatment
included a simultaneously integrated boost to the bladder tumour. Patients not
suitable for SIB were treated with an empty bladder [82]. The whole bladder was
delineated on the planning kVCT scan and 6 adaptive PTVs were grown by adding
isotropic margins from 5 mm to 30 mm in 5-mm steps. 6 IMRT plans were created
for each patient. The MVCT images taken before treatment were automatically
registered to the planning kVCT image by matching the bony anatomy and after
that, the smallest possible PTV was selected by manually matching the bladder to
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fit inside the PTV volume with a 2–3-mm margin [82].
As well as adaptation of the planning target volume size, there can be adaptation
to the position of the bladder or to the position of the tumour. Wright et al.
compared three different strategies for correction of the isocentre [76]. The first
was no translation of the isocentre, the second was an optimal translation of the
isocentre to maximize the overlapping CTV volumes between the repeat CTV and
the planning CTV. The third was a shift to the tumour location, studied for 6
possible locations of the tumour, which is the most relevant when considering the
tumour boost [76]. For each of the three strategies, Wright et al used an algorithm
to formation of both anisotropic and isotropic margins by finding the PTV enclosing
all possible repeat CTVs, and the daily adaptation PTV enclosing only the CTV of
the day [76]. They compared the achieved volume overlaps between the bladder of
the planning CT scan and the repeat scan.
Wright et al. found the daily translations to the tumour position and volume
adaptation to the CTV of the day to increase the average percentage volume overlap
by 20% to 79–82% for the various tumour positions, compared to the optimization
of all repeat CTVs [76]. The achieved volume overlap was similar with no transla-
tion of the isocentre and slightly higher with optimal translation according to the
bladder. They concluded that the translation of the isocentre according to the tu-
mour position did not lead to increased normal tissue irradiation compared with no
translation Optimal translation of the isocentre according to the tumour position
was superior in terms of normal tissue sparing [76].
2.5 Helsinki and Aarhus methods
2.5.1 Introduction
In the method used in Helsinki University Central Hospital developed by Tuomikoski
et al., four treatment planning CT images with different bladder filling states are
acquired and based on the CTV volumes delineated on the images, a set of treatment
plans are made [9]. The plan of the day is chosen based on the visible extent
of bladder wall in CBCT images, i.e. the CTV. The position of the PTV in the
treatment is adjusted to the daily bladder position with soft-tissue registration.
In the method used in Aarhus University Hospital [10; 80], the treatment plan for
the first week is made based on one treatment planning CT image with large margins.
CBCT-images of the patient are taken every day during the first week and three
alternative planning target volumes are constructed based on Boolean operations to
the the bladder contours delineated in the treatment planning CT image and the
four CBCT images. These CBCT images are registered to the treatment planning
CT image based on bony anatomy in patient positioning. During the course of the
treatment, the plan of the day is chosen of separate plan selection volumes (PSVs)
[10; 80].
There are three major differences between the methods: the way to form the
PSVs, the way to register the treatment CBCT images to the planning CT image
and the different treatment margins. Table 4 and Figure 6 visualize a comparison
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of the methods.
Table 4: Comparison of the Helsinki and Aarhus methods.
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2.5.2 Helsinki method
In the Helsinki method, the idea is to determine the changes of volume and shape
of the bladder due to filling. The patients drink 8 dl and empty their bladder. Four
repeated CT scans are acquired in supine position using a knee and feet fixation
system. The scans are taken with a 15-min interval between the successive scans,
the first scan being acquired shortly after voiding. The images are imported in the
treatment planning system. The images are registered to the first image with the
empty bladder with an automized rigid registration algorithm of the TPS based on
the bony anatomy. [9]
The bladders plus areas of extravesical extension representing the CTVs in the
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Figure 6: The ideas behind the Helsinki (A) and Aarhus (B) methods. In the
Helsinki method (A), the objective is to catch the individual bladder filling pattern
of the patient. Repeat CT images are aqcuired every 15 minutes, starting from the
empty bladder (cyan) and stopping after 45 minutes (red). The bladder contours
in these images are used as a starting point when producing the planning target
volume. In the Aarhus method (B), the bladder contour of the planning CT image
is combined with four CBCT scans aqcuired on consecutive treatment days of the
first week of treatment to produce the starting point for the PTV formation. The
aim of the Aarhus method is to catch changes in the bladder form and position over
time.
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treatment planning images are manually contoured by a radiation oncologist and the
contours are then used to form the alternative planning target volumes. This way the
patients’ individual bladder filling pattern is defined. Also the surrounding normal
structures are delineated by the radiation oncologist. These structures include the
rectum, the intestinal cavity and the femoral heads. The patients usually receive
fractionated RT that is divided in two parts. The elective part, which is given
first, includes the whole bladder (and in some cases the lymph nodes) as elective
treatment volume and is usually treated to 45–50.4 Gy with 1.8-Gy fractions. The
boost part includes only the tumour with margins and this volume is treated to a
total dose of 10–20 Gy in 2-Gy fractions, depending on the patient tolerance. [9]
The planning target volume is formed by anisotropically extending the CTVs
with anterior and cranial margins of 10 mm and lateral, posterior and caudal margins
of 15 mm [9]. The treatment plans are made with volumetric arc therapy or intensity-
modulated radiation therapy techniques. 4 treatment plans for the whole bladder
and 4 plans for the boost are made.
The patient is instructed to void their bladder prior to each treatment session.
The treatment is delivered based on the daily CBCT acquisition and the online reg-
istration of the CBCT images to the planning CT image is made with an automatic
soft-tissue registration algorithm. According to the current procedure in Helsinki,
the radiographers choose the plan with the smallest PTV for the specific treatment
fraction so that the bladder visible in the CBCT image fits inside the planning CT
bladder. In the Helsinki method, no separate plan selection volume is formed but
the planning CT bladder, i.e. the CTV, is directly used as the PSV. The whole
CTV–PTV margin thereby accounts for the intrafractional changes.
2.5.3 Aarhus method
In the Aarhus method, the idea is to account for the day-to-day changes in the
bladder shape and position. One treatment planning CT scan is taken after the
patient has emptied their bladder and the images are imported and registered in the
treatment planning system. The clinical target volumes for the bladder, including
the bladder wall and its contents, and for the lymph nodes are delineated. In the
Aarhus method, the lymph nodes are often included in the treatment. The total
dose of the treatment is 60 Gy in 2-Gy fractions. [10]
The PTV for the first week of the treatment is formed as follows: First, an
internal target volume (ITV) covering the internal variations in the bladder position
is formed by adding an anisotropic margin to the bladder CTV. The margin width
is 20 mm anterior and superior, 15 mm posterior and 10 mm in the remaining
directions. To account for the external setup variations a margin of 5 mm in the
axial plane and 8 mm in the cranial–caudal direction is applied. The treatment
is delivered after set-up based on CBCT acquisition and online image registration
based on bony anatomy. This applies to the whole course of the treatment. [10]
After the treatment of the first week has been given, 3 alternative PTVs for the
adaptive treatment are formed based on the CBCT images taken during the first
four fractions and the planning CT scan. The CTVs are delineated on each image
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and the images are registered using the bony-anatomy match [10]. The small PSV
is the volume covered by at least two of these five bladder contours plus a 3-mm
margin to compensate the registration of the images based on bony anatomy. The
medium PSV is the union of these five bladder volumes plus the same 3-mm margin.
To form the small and medium PTVs, a 5-mm intrafraction margin is added to these
composite CTVs (Figure 7). The large PTV is the same as the PTV of the first
week’s treatment [10]. The treatment plans are made with IMRT planning [80].
Figure 7: The small (A) and medium (B) composite CTV in the Aarhus method.
The small composite CTV is the volume covered by at least two of the 4 CBCT
and 1 planning CT bladders. The medium composite CTV is the union of these five
bladders. The PSVs are formed by adding a 3-mm margin.
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3 Methods
3.1 Patients
In total 10 patients with muscle invasive bladder cancer were retrospectively selected
for the study. 8 males (patients 1–8) and 2 females (patients 9–10) were selected in
order to represent the typical population of bladder cancer patients. The patients
had been treated in Helsinki University Central Hospital between 2010 and 2014.
4 of the patients, 1 female and 3 male, had been treated with Varian Clinac iX
with the OBI kV on board imaging system. 6 patients, 1 female and 5 male, had
been treated with Electa Axesse machine. This linear accelerator is also equipped
with a kV on board imaging system, called XVI. Patients 1, 3, 5 and 10 had been
treated with the Varian linear accelerator and the rest with the Elekta linac. 6 of
the patients had received a whole bladder treatment and 4 a treatment for the whole
bladder with the pelvic lymph node areas included (patients 5, 6, 7 and 10).
The CBCT images taken during the treatment were used as the material for
this study. The patient needed to have received at least 30 fractions of treatment in
order to have an adequate number of CBCT-images to be included into the analysis.
The patients had been treated to varying doses and the amount of images taken
during the treatment varied between the patients. However, the Aarhus University
hospital usually treats the patients to a total dose of 60 Gy in 30 2-Gy fractions
[10] and thus, the total amount of 30 images was chosen to be included to the
analysis. An additional prerequisite was that four planning CT series had to have
been successfully acquired in order to be able to form the PTVs according to the
Helsinki method.
3.2 Simulating the treatment
3.2.1 Image registrations
There were three kinds of registrations in the study: bony-anatomy based registra-
tions, centroid-based registrations and registrations based on soft-tissue anatomy.
All of the images were first registered based on bony anatomy. The bladder con-
tours delineated in the CBCT-images were transformed into the treatment planning
CT according to this registration. These bony-anatomy matches were also utilized
as such to evaluate the hits and misses in the Aarhus method and the modified
Helsinki method where the bony-anatomy match was used.
The radiotherapy planning CT image and the CBCT images were registered
using bony-anatomy matching. Here an automatic tool in MIM R© medical image
management software (MIM Software Inc., Cleveland, OH, USA) was first used
to match the images together approximately. After this, the software’s box-based
assisted alignment tool was used to refine the registration. The MIM R© software
uses a registration algorithm which does the matching based on both soft tissues
and bony anatomy. However, the focus was on the bones while evaluating the quality
of the registration. The bones surrounding the bladder were included to the box.
The femoral heads were included but the rest of the femur was excluded, since the
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patient’s legs could be in a slightly different position. The symphysis was included,
but the anterior abdominal wall was excluded to avoid the breathing movement
to influence the matching. Respectively, the spinal cord was included but the soft
tissues lying more posteriorily were excluded from the box. Superiorily the box
reached at least the superior border of the CBCT image. An example of the region
of interest for the image registrations is shown in Figure 8.
Figure 8: The box-based alignment region of interest.
In Helsinki University Central Hospital, rotational variations are currently not
corrected for with table rotations in the case of bladder patients. To be able to follow
the procedure of the treatment as precisely as possible, the matching of the images
was done without rotation. In Aarhus University Hospital the current procedure
includes correction for small rotational deviations, but as this is a recent change in
the procedure, this was not taken into account, in order to simplify the analysis.
In the later phases of the analysis there were also registrations based on the mass
gravity centres of the daily bladders and the alternative PSVs. The centroids of the
bladders and the alternative PSVs were found with the automatic tool of the MIM R©
software and manually aligned with the MIM R© software transformation tool. The
tool finds the mass gravity center of the contour, treating all voxels as same density.
In the Helsinki method, a soft-tissue registration is made between the treat-
ment planning CT and the treatment CBCT images. When comparing the original
non-modified methods, this soft-tissue registration could not be performed in the
exact same way as in the treatment. On the treatment machine there is automatic
software for soft-tissue matching and the radiographers are allowed to refine the
result if it is not satisfactory. In the MIM R© software, there is no such tool. The
soft-tissue registration in the Helsinki method was simulated by using the centroid
registration as an objective starting point and refining this registration manually to
get the bladder of the day to fit into the smallest possible PSV, trying to keep the
required translations as small as possible. It is emphasized that all the analyses were
performed retrospectively and they did not have any effect on the patients’ actual
treatments.
3.2.2 Delineation of the bladders
For the 10 patients, the bladders and intestinal cavities in the CBCT images were
delineated in cooperation with a radiation oncologist. Even though the pelvic lymph
node areas had been included to the treatment area or some patients in the actual
treatment, for the purpose of this simulation only the bladder was included to the
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target area. The CBCT images of 30 fractions of the treatment were included to
the analysis. In the case that there were more than 30 images available, the 30 first
images were taken into analysis. If the patient had been imaged twice during the
fraction, pre and post treatment, the first of the images was chosen.
The bladder was delineated utilizing axial, coronal and sagittal directions of the
image. In the case of partial volume artifacts, the larger volume was contoured if in
doubt. The guideline ’err on the generous side’ [49] was hence followed.
3.2.3 Target volumes
The target volumes were formed according to three different ways: 1) using Helsinki
method as such, using the Helsinki method margins, 2) forming the PSV according
to Helsinki method, but using Aarhus margins, and 3) using the Aarhus method.
In the Helsinki method, the CTVs on the four treatment planning CT images
taken immediately after emptying the bladder (CT0) and every 15 minutes (CT15,
CT30, CT45) were expanded with anisotropic margins to form the alternative PTVs.
The bladder was used as the CTV as such, assuming for the purpose of this study
that the subclinical growth would be restricted to the bladder walls. According to
the current procedures in the treatment in Helsinki, the bladders delineated on the
treatment planning images, i.e. the CTVs, were used as plan selection volumes.
In the Aarhus method there were three alternative planning target volumes:
small, medium and large. Each of these planning target volumes were constructed
differently. Whereas in the Helsinki method the PTV was formed by adding margins
to the bladder which was straightforwardly used as the CTV, in the Aarhus method
additional PSVs were formed in order to form the PTV. The treatment planning CT
scan (CT0) and the CBCT-images of the first four treatment fractions were used to
form the small, medium and large PSVs as described earlier in this text.
In order to be able to compare the Helsinki and Aarhus methods to form the
PSV, without that the comparison would be influenced by the margins or the image
registration method, the Helsinki adaptive RT method was modified. The Helsinki
method to form the CTV was combined with Aarhus method margins to form this
modified method. The way and the margins to form the alternative PSVs and
PTVs according to the modified and non-modified Helsinki and Aarhus methods is
summarized in Table 5. To make the margin formation quicker and more easily
reproducible, an automated workflow for the MIM R© software was designed. The
result was checked manually for all of the margins.
3.2.4 Selection of the daily target volumes
After creating the alternative PTVs and PSVs for each method, the simulation of the
treatment continued with the selection of the daily treatment volumes. The same
basic principles applied for all methods: the smallest possible treatment volume
was chosen so that the bladder of the day fit into the corresponding PSV. In this
chapter, the treatment volume selection procedure is reviewed for all of the evaluated
methods.
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Table 5: PTV formation in each method. Directions: ant. = anterior, post. =
posterior, sup. = superior, inf. = inferior, lat. = lateral
Method PTV Bladder contours Operation before PSV Intrafraction
to start with margin addition margin margin
Helsinki PTV A–D 4 Planning CTs, None 0 mm anisotropic
actual 15 min intervals ant. & sup.
10 mm
lat., post. &
inf. 15 mm
Helsinki PTV A–D 4 Planning CTs, None isotropic isotropic
modified 15 min intervals 3 mm 5 mm
Aarhus PTV S Planning CT & At least two bladders isotropic isotropic
actual & 4 CBCTs (Figure 7) 3 mm 5 mm
modified
PTV M Planning CT & Union isotropic isotropic
4 CBCTs (Figure 7) 3 mm 5 mm
PTV L Planning CT None anisotropic anisotropic
ant. & sup. sup. & inf.
20 mm 8 mm
post. 15 mm remaining
remaining 5 mm
10 mm
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It seems natural to start with the Aarhus method, since in that method the
registrations between the treatment planning CT and CBCT images are the same
bone-based registrations used when transforming the bladders from the CBCT im-
ages to the treatment planning CT. The selection of the PTV was done by looking
at the contours of both the bladder of the day and the alternative PSVs and simply
choosing the smallest PSV into which the bladder contour would fit. The contours
were allowed to coincide but the bladder could not come out of the PSV contour
so that there would be a gap between the delineated contours. The same principle
as in the Aarhus method was followed when choosing the smallest Helsinki method
PSV created using Aarhus margins that would cover the bladder. The PSVs were
examined one by one, starting from the smallest and comparing them to the bladder
of the day as described earlier.
The procedure of treatment volume selection is a bit more complicated for the
methods including some other way to register the images than the bone match. The
principle of these image registrations was described earlier in the related chapter.
The bladders were in the CBCT images and the possible PSVs in the treatment
planning CT so that changing the registration between these images changed the
position of the contours in respect to each other. There were concerns of how to
perform these registrations objectively and so a compromise was made. Matching
the mass gravity centres of the contours was thought to simulate the soft-tissue
match well enough. Both Aarhus and Helsinki methods now used this centroid
match and the margins of Aarhus method.
Matching based on the contour centroids was performed as follows. Starting with
the smallest PSV, the centroids of the PSVs were matched with the bladder centroid
one by one and the one covering the whole bladder was chosen. If the bladder was
not covered by even the largest PSV, it was recorded if at least the largest PTV
covered it. If not, the severity of the miss was noted.
The soft-tissue registration belonging to the Helsinki method was performed us-
ing the centroid match as a starting point. Each PSV, starting with the smallest
one, was evaluated until the smallest possible PSV was found. However, after match-
ing the centroids, it was also tested whether the bladder could fit into the PSV by
making some translations. If, for example the smallest PSV was clearly too small
for the bladder, the next smallest one was matched based on the centroids. If the
bladder did not fit the PSV with the centroid match, it was evaluated if it could be
made to fit by making a small translation. The aim was to find the smallest possible
PSV that would cover the bladder but also to do this with as little translations as
possible. If even the largest PSV did not cover the bladder, it was checked whether
the largest PTV would cover the bladder without any translations. If not, it was
clarified whether it was possible to get the bladder into the PTV by making some
translations.
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3.2.5 Comparison of the plan selection frequencies with those in the
treatment
The plan selection frequencies were compared with the plan selection frequencies
observed in the actual treatment. The plans with which the patients had been
treated were listed for each fraction. In this simulation the bladder was used as the
target as such, but in the treatment the regions of extravesical tumour expansion
were also included. For some of the patients (5, 6, 7 and 10) the lymph nodal
areas were also included to the treatment volumes and bony-anatomy registration
was used. These patients were left out to have a more representative selection of
patients treated with the Helsinki method. Nevertheless, the PTVs in the treatment
might not have been the same as in the simulation for all of the patients, as the
treatment protocol can be adjusted to the individual needs of the patient by the
treating oncologist.
For some of the patients, there were less than four different options for a treat-
ment plan. In these cases the bladder expansion between some sequential CT scans
had probably not been strong and the treating oncologist had decided that there
is too little difference between the two bladders for both options to be useful. To
be able to make some rough comparison of the selected volumes, the plan made
based on the post-void planning CT was named as A, the plan made based on the
15 minutes CT image was named B and so forth.
There had been different fractionation schedules in the treatment and usually a
booster had been included, and hence the treatment with the PTVs formed according
to the described Helsinki method had not lasted for 30 fractions. The relative ratios
of the frequencies of the treatment plans were calculated.
3.3 Feasibility of soft-tissue image registration when irradi-
ating pelvic lymph nodes
When treating the bladder and the lymph node areas, if the patient’s position is
adjusted based on the CBCT images so that the bladder is in an optimal position
with regards to the PTV, an error is induced to the lymph node region. The lymph
nodes are in a relatively stable position with respect to the bony anatomy, so re-
garding the lymph nodes, it would be ideal to adjust the patient’s position based on
bony-anatomy registration, which is the case in the treatment if the lymph nodal
areas are included to the target volume. The eligibility of the soft-tissue registration
in the case of treatment of both the whole bladder and the lymph nodes was further
examined by a simulation. It was calculated, how large a CTV–PTV margin needs
to be added to the lymph nodes in order to correct for the error caused by regis-
tration of the images based on soft tissues and not the bony anatomy. The formula
(3), which was introduced by van Herk et al. [21], was used.
First, the translations from bony anatomy to soft-tissue anatomy in each direc-
tion x, y and z on each treatment fraction were calculated for individual patients.
The coordinate system was that used by the MIM R© software. Here the x direction
was the lateral direction with the positive direction pointing to the left. Coordinate
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y was the anterior posterior axis and the positive direction was the posterior direc-
tion. The z axis was in the cranial caudal direction, the positive direction being the
caudal direction. The coordinate system is visualized in Figure 9.
Figure 9: The coordinate system in the MIM R© Software. The positive directions are
indicated by the arrows. When performing an image registration, the planning CT
image was chosen as the primary image. This means that in all the registrations,
the CBCT image is moved according to the planning CT image.
The coordinates indicating the translation between the treatment planning CT
image and CBCT image acquired before treatment were listed for each fraction of
each individual patient, separately for the soft-tissue registration and the bony-
anatomy registration. The coordinates of soft-tissue registration were subtracted
from the coordinates of bony-anatomy registration. The individual means and stan-
dard deviations for each patient were calculated by taking the average and standard
deviation across all fractions for each patient. The group systematic error M was
the mean of the patients’ individual means and Σ was the standard deviation of
the individual means, which represents the standard deviation of the systematic er-
ror. The standard deviation of the random error, σ, was calculated as a root mean
square (4)
R (x) ≡
√
〈x2〉 (4)
of the individual standard deviations, where the 〈...〉 stands for the arithmetic mean.
The penumbra width parameter σp was calculated by dividing the measured
penumbra width by 2.56 [15]. Based on the 6 MV photon inline profile measurements
for HUCH linear accelerator 6 the distance between the 10% and 90% dose levels of
a single beam at a typical treatment depth (10 cm) was calculated. The field size
used in the measurements was 10 cm x 10 cm. The distance between these dose
levels was 2.07 cm. As the respective distance for linear accelerator 3 was similar
(1.99 cm), we decided to use the linear accelerator 6 penumbra width value for all the
patients for simplicity. Thus, the value of parameter σp was 8,1 mm. The treatment
planning system photon beam algorithm error, a, was approximated to be at most
half of a typical calculation grid size of 3 mm. Hence, the calculation grid size was
the limiting factor.
The breathing error b was assumed here to be zero. Respiratory-induced prostate
motion has been found to be less than 1 mm in the vast majority of fractions in
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all directions in the supine position [84–86]. The bladder motion induced by the
breathing has not been studied to our knowledge but it can be assumed to be
similar to the prostate motion due to respiration. As the movement is assumed to
be modest compared to the bladder movement in total, the breathing positional
error b was set to be zero.
The parameter β which depends on the field set-up was taken from [32]. The
total number of the irradiating beams in a typical IMRT-plan for bladder RT is
7, but we used the value for a 6 field plan. The formula introduced by McKenzie
et al. for calculating the value of the parameter β underestimates the value of the
parameter at high beam numbers [32]. McKenzie and colleagues report that up to 6
beams, the table is satisfactory. However, as the parameter decreases as the number
of the beams increases, it was considered safe to use the β value for a 6-field plan
also for the 7-field plan as it would at worst overestimate the margin needed. As
there are no parallel or opposing beams on the IMRT plans, the parameter β value
in the x and y directions was 0.52 and in the z direction it was 1.64.
3.4 Statistical analysis
Statistical methods were used in the analysis of the results. These methods included
linear regression modeling, the F-test for statistical significance of the regression
coefficients, the paired t-test and the Pearson correlation coefficients. These methods
are briefly described.
In linear regression analysis, the goal is to model the relationship between the
dependent variable y and one or more explanatory variables x with a linear equation.
The equation
yi = f (xi; β) + i (5)
describes how the variation of variable x explains the variation of variable yi. β
is the parameter vector containing the regression coefficients. The term i is the
error term that catches all other factors influencing the dependent variable y, other
than x. Other than forming a model to explain some phenomenon with possible
explanatory variables, linear modelling can be used to quantify how strongly y is
influenced by the x that is suspected to be related to y. The value of parameter β is
chosen so that the values of the error terms i are minimized. In this analysis, this
curve fitting problem was solved with the least squares method, which minimizes
the quadratic sum of the error terms
n∑
i=1
2i =
n∑
i=1
(yi − f (xi; β))2 (6)
The regression coefficients can be tested with the F-test. The F-test is performed
using formula
F = (n− 2) R
2
1−R2 (7)
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The R2 value of the model describes how many per cent of the variation of the
dependent variable can be explained by the explanatory variable(s). The n − 2 is
the number of degrees of freedom. If the value of F is large, this suggests the null
hypothesis that the regression coefficients are all zero to be false.
The paired t-test can be used when it is reasonable to arrange the observations as
pairs [87]. In the t-test the differences between the numbers in the pair are calculated
and the mean of these differences is assumed to be zero. The t-test quantity is
t =
D¯
sD/
√
n
, (8)
where
D¯ =
1
n
n∑
i=1
Di (9)
and
s2D =
1
n− 1
n∑
i=1
(
Di − D¯
)2 (10)
The paired t-test assumes that the values are normally distributed, but if the
number of observations is large enough (n > 40) it can be safely used even for clearly
skewed distributions [87].
The Pearson correlation coefficients can be calculated according to the formula
rxy =
∑n
i=1 (xi − x¯) (yi − y¯)√∑n
i=1 (xi − x¯)2
√∑n
i=1 (yi − y¯)2
, (11)
where x¯ is the arithmetical mean of the values of x and y¯ is the arithmetical mean
of the values of y.
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4 Results
4.1 Bladder volumes during the course of the treatment
Based on the delineated bladders on the CBCT images, some statistics of the ob-
served bladder volumes were calculated (Table 6). In the patient population, the
bladder volumes during treatment ranged from 42 ml to 343 ml. Daily bladder
volumes were observed throughout the treatment (Figure 10).
Table 6: Bladder volumes of each patient (ml). The mean bladder volume across
the treatment fractions, the standard deviation (SD) of the bladder volume and the
minimum as well as maximum bladder volumes are presented.
V(bladder)
Patient Mean SD Min Max
[ml] [ml] [ml] [ml]
1 145 31 106 223
2 106 22 76 176
3 108 22 69 163
4 112 39 80 251
5 157 35 123 266
6 90 28 42 156
7 131 24 102 198
8 188 43 145 343
9 112 49 51 271
10 121 53 59 227
Figure 10: The daily bladder volumes relative to the volume of the empty bladder
on the planning CT scan.
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There seemed to be a trend that the bladder volumes decrease during the treat-
ment (Figure 10). A linear regression line was fitted with the least squares method.
A model was constructed to explain the bladder volume variations during the course
of the treatment with the increasing fraction number. Based on the regression lines
fitted to the bladder volume data of individual patients, 8 of the 10 patients studied
had a decreasing tendency in the bladder volume during treatment. Only patients
3 and 6 had a positive regression coefficient. A linear regression curve was fitted to
describe how the fraction number (time) affected the bladder volume.
The F-test found at least one of the regression coefficients to differ statistically
significantly from zero. The fraction number had a significant negative coefficient
of –1.28 (p < 0.001), meaning that the bladder volumes significantly decreased as a
function of the treatment fraction. However, a linear relationship with the fraction
number is not enough to explain all the variations in the bladder volume (R2 = 0.06,
adjusted R2 = 0.06). The change in the fraction number explained only 6% of the
bladder volume value variations.
On 67% (20/30) of the fractions the bladder had a smaller volume than in the
planning CT scan. One can ask if the bladder volume in the planning scan is
representative of the bladder volumes during the course of the treatment. However,
the bladder volume also varied during treatment (Figure 11). On patients 1, 2, 3,
5 and 7 the maximum bladder volume in the treatment exceeded the volume of the
45 minute CT scan bladder.
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Figure 11: Individual bladder volume change due to filling measured from the plan-
ning CT scans taken during an hour. The error bars around the mean CTCB bladder
represent the range of the bladder volumes during treatment.
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4.2 Comparison of Aarhus and Helsinki methods
4.2.1 Plan selection frequencies and hitting the target
There are three procedural differences between the methods: The method to form
the CTV, the CTV–PTV margins and the method for registration between the
planning CT and CBCT images. The purpose was to compare the Helsinki and
Aarhus methods for forming the CTV. We wanted to see the effect of only the CTV
forming method without the effects of the margins and the registration method.
Also the non-modified methods were compared. The success of the radiotherapy
treatment depends on whether the target is hit or missed. The compared methods
were evaluated in this respect. The frequencies of the selected PTVs were listed and
the success of the treatment fractions was reported.
In the next figures, the frequencies of the different PTV selections in the different
methods are presented. The black and white scale represents the safe zone, where
the bladder of the day has fit into the plan selection volume, in the case of the
Helsinki method, one of the treatment planning CTVs. The red colour indicates
the worst case, where the bladder of the day has not fit into even the largest PTV.
In the cases marked with yellow colour, the largest PSV was not adequate but at
least the bladder fit into the PTV in the beginning of the treatment. In these cases
one cannot be certain whether the intrafractional changes in the bladder size are
still accounted for. In red and yellow cases patient would be asked to void their
bladder again. These situations would hence not pose a threat to the success of the
treatment but would be inconvenient and slow down the treatment.
To equalize all the other components than the way to form the CTVs between
the different methods, we first decided to try and change the registration method
and the CTV–PTV margins of the Helsinki method to those of the Aarhus method.
That is, the margins were according to the Aarhus method and the registration of
the images was done based on the bony anatomy.
When using the bone match, the Aarhus margins were clearly not adequately
large when the Helsinki method for forming the CTV was used (Figure 12). The
PTV is frequently too small in the simulation when applying this modified method.
The Aarhus method, being non-modified, worked properly and will be addressed
later in this chapter.
The next way of comparison of PSV formation was to utilize the Aarhus method
margins and Helsinki method registration for both methods (Figure 13). In Helsinki,
the method to register the treatment CBCT images to the planning CT image is
soft-tissue matching, which was simulated with the centroid registration for the
objectivity of this comparison.
The Aarhus method with the centroid match seemed to be applicable. For
Helsinki method, compared to the bony-anatomy registration, the centroid registra-
tion decreased the rate of inadequate PTVs. However, in some cases, the planning
target volumes would not have covered the CTV in the modified Helsinki method
with the Aarhus method margin and centroid match.
The next step was to compare the plan selection frequencies of the methods as
such, non-modified (Figure 14). Based on this simulation, the majority of the chosen
48
Figure 12: Plan selection frequencies with the modified Helsinki method for each
patient. The planning target volumes were formed with the Helsinki method, but
using the Aarhus method margins. The planning CT and treatment CBCT images
were registered based on bony anatomy.
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(a) Helsinki method with centroid registration and Aarhus margins
(b) Aarhus method with centroid registration
Figure 13: (a) Plan selection frequencies with the modified Helsinki method for
each patient. The planning target volumes were formed with the Helsinki method
but using Aarhus method margins. (b) Plan selection frequencies with the modified
Aarhus method for each patient. The planning target volumes were formed with the
Aarhus PTV formation method using the Aarhus method margins. In both (a) and
(b), the planning CT and treatment CBCT images were registered based on a point
match of the centroids of the bladder and the PTV. This was thought to adequately
simulate the soft-tissue matching.
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(a) Helsinki method
(b) Aarhus method
Figure 14: (a) Plan selection frequencies with the Helsinki method for each pa-
tient. The planning target volumes were formed with the Helsinki method using the
Helsinki method margins and the planning CT and treatment CBCT images were
registered based on soft-tissue anatomy. (b) Plan selection frequencies with the
Aarhus method for each patient. The planning target volumes were formed with the
Aarhus method using the respective margins and the planning CT and treatment
CBCT images were registered based on bony anatomy.
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treatment plans in the actual Helsinki method would have been the ones with the
largest planning target volume (Figure 14a). For some patients, the largest planning
target volume PTVD was even the only one ever chosen. The method doesn’t hence
seem to be truly adaptive. However, one must pinpoint that since the PTVs are
not frequently too small as they were in the modified Helsinki methods, the method
seems to work. Also, in the Helsinki method, part of the adaptation comes through
the soft-tissue registration and the ability to make transformations to the position
of the patient according to the position and shape of the bladder.
In the Aarhus method the chosen alternative PTVs were quite evenly distributed
and also the smallest plans were chosen often (Figure 14b). In the case of some
patients, there are also some fractions where even the largest PTV volume was
inadequate.
4.2.2 PTV and PSV volumes
To analyze the differences between the methods and to understand how the target
volumes available guided the plan selection, the PTVs and PSVs were compared
between the methods. The PTV volumes (Figure 15) and the PSV volumes (Figure
16) of the modified Helsinki and Aarhus methods were first compared.
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Figure 15: PTV volumes of individual patients in the modified Aarhus and Helsinki
methods with centroid and bony-anatomy registration. The error bars indicate the
range of the CBCT bladder volumes observed during the treatment.
In the case of the modified methods using centroid or bony-anatomy registra-
tion, Aarhus margins were used also for the Helsinki method PTV formation. This
resulted in smaller PTVs for the Helsinki method, as the CTV–PTV margin was
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added to a single bladder contour instead of the composite volumes used in the
Aarhus method. There is also more variation in the Aarhus planning target vol-
umes, providing a wider range of possible choices (Figure 15).
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Figure 16: PSV volumes of individual patients in the modified Aarhus and Helsinki
methods with centroid and bony-anatomy registration. The error bars indicate the
range of the CBCT bladder volumes observed during the treatment.
In the modified methods, the PSV volumes are formed by adding a 3-mm margin
to the planning CT bladders in the case of the modified Helsinki method and to the
composite volumes in the case of the Aarhus method. As for the PTV volumes, the
Aarhus method PSV volumes have a wider range and are larger than the modified
Helsinki method PSV volumes (Figure 16).
When comparing PTVs of the clinically used Aarhus and Helsinki methods (Fig-
ure 17), one can observe that the Aarhus PTVs again have a wider range in volume.
The smallest PTV is smaller and the largest PTV is larger than in the Helsinki
method. However, just by comparing the volume of the bladders during treatment
and the PTV volumes in each method, one can say that the PTVs in both methods
should be able to accommodate the bladder volumes observed during the treatment.
Plan selection volumes are the volumes where the daily bladder needs to fit in
order for the PTV to be selected, that is, the PSVs of the clinically used methods
(Figure 18). In the case of the Helsinki method, the daily bladder has to fit inside
one of the planning CT bladders. The available PSV volumes are smaller in the
Helsinki method. As the intra-fraction margin in the Aarhus method is 5 mm, it is
10–15 mm in the Helsinki method.
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Figure 17: PTV volumes of individual patients in the actual Helsinki and Aarhus
methods. The error bars indicate the range of the CBCT bladder volumes observed
during the treatment.
0
100
200
300
400
500
600
700
0 1 2 3 4 5 6 7 8 9 10 Mean
PS
V 
vo
lu
m
e 
[m
l]
Patient 
PSVA
PSVB
PSVC
PSVD
PSVS
PSVM
PSVL
Mean CBCT bladder
Figure 18: PSV volumes of individual patients in the actual Helsinki and Aarhus
methods. The error bars indicate the range of the CBCT bladder volumes observed
during the treatment.
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4.2.3 Further comparison of methods
The objective of the study was to compare the way to form the CTV in each method.
To do this, all the other differences between the methods were made equal between
the methods. Two ways to do this were tried, first to register the images in both
methods according to the bony anatomy and use the Aarhus margins for both meth-
ods and secondly to register the images in both methods with the centroid registra-
tion and use the Aarhus margins for both methods. Also, to compare the methods
as they are clinically used, we simulated the treatment according to both methods
as they are actually done. The plan selection frequencies were compared in the pre-
vious chapter but the methods were also compared in more detail. In this chapter,
these analyses are presented.
According to the diagrams about plan selection frequencies (Figures 12–14) there
were some cases that the largest PTV was inadequate to accommodate the CTV
of the day. In these situations the patient would have been requested to void their
bladder again, which would have slown down the treatment. Of the 300 fractions,
the number of occations when there was bladder volume outside the PTV was 100
for the Helsinki method with bony-anatomy registration and Aarhus margins. The
maximum volume of bladder outside the PTV was 14 ml. These figures indicate
that the modified Helsinki method would not have functioned in the treatment.
Hence, there was no point in comparing this modified method to the non-modified
and functioning Aarhus method and further discussion was omitted.
The second way to compare the PSV formation ways between the methods was
to use the centroid registration as a surrogate for the soft-tissue registration. Both
methods now used this centroid registration and the margins of the Aarhus method
were used for the Helsinki method as well. The different alternative planning target
volumes were quite evenly chosen in both methods (Figure 13). This indicated that
the methods work and the volume of the chosen PTV seems to be adapted to the
volume of the bladder. In the modified Aarhus method, the distribution of the
chosen plans was even more even than in the modified Helsinki method.
PTV outside bladder volumes can be used as a surrogate for the volume of
normal tissues, particularly intestinal cavity volume, irradiated to the treatment
dose. These volumes are listed in Table 7 for each method in the comparison.
Table 7: PTV outside bladder volumes for each of the compared methods. The
mean and median value, as well as the standard deviation and the range of the PTV
volume outside bladder are reported.
PTV volume outside bladder Mean Median SD Min Max
[ml] [ml] [ml] [ml] [ml]
Aarhus – bony-anatomy registration 494 515 168 113 865
Helsinki – soft-tissue registration 504 517 120 279 805
Aarhus – centroid registration 468 491 182 112 892
Helsinki – centroid registration with Aarhus margins 314 300 90 143 556
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The chosen PTV volumes were found to be significantly smaller in the modified
Aarhus method than those in the non-modified Aarhus method, as was indicated by
the paired comparison t-test (t =2.97, p < 0.01). There was only one fraction where
the largest PTV volume was too small, whereas there were two such fractions in
the actual clinically used Aarhus method. The severity of the miss was 1 ml for the
modified method and 5 ml for the non-modified method. There was no difference
in the volume of bladder outside PTV. However, the PTV volume outside the daily
bladder was smaller for the modified Aarhus method with centroid registration (t =
2.97, p < 0.01).
The Helsinki method was modified both in respect of the registration method and
the margins. There were 22 occasions where the largest PTV was not adequate, the
largest bladder volume outside the PTV being 3 ml, whereas there were none in the
simulated clinically used method. Not surprisingly, the chosen PTV volumes were
statistically significantly different between the modified and non-modified Helsinki
method. The PTVs of the non-modified Helsinki method were larger than those of
the modified method (t = 48.59, p < 0.001). The bladder volume outside PTV was
significantly smaller in the non-modified method (t = –2.71, p < 0.01). However, as
was expected since the PTV volumes were larger in the non-modified method, the
PTV–bladder volumes were significantly smaller for the modified Helsinki method
(t = 47.49, p < 0.001).
The average volumes of the patients’ chosen PTVs during the treatment were
compared between the modified Aarhus and Helsinki methods with the centroid
registration (Figure 19). It seems that the PTVs chosen according to the modified
Aarhus method are on average larger for all 10 patients. To test whether the visible
difference is statistically significant, the paired t-test was applied. The t-test indi-
cated that the Aarhus modified PTV volumes were larger than the Helsinki modified
PTV volumes (t = –16.29, p < 0.001). As could be anticipated from the number
of missed fractions, the bladder outside PTV volumes were larger for the modified
Helsinki method (t = –2.67, p < 0.01). As the PTVs of the modified Aarhus method
were found to be significantly larger, so were also the PTV–bladder volumes (t =
16.30 and p < 0.001).
The average volume of the PTVs chosen for treatment on each fraction was
compared between the clinically used non-modified Aarhus and Helsinki methods.
According to the paired t-test there was no statistically significant difference between
the PTV volumes of these actual methods (Figure 20). The bladder outside PTVs
volumes did not differ between the methods either, nor did the PTV outside bladder
volumes.
To analyse the plan selection statistically, correlations between the bladder vol-
ume and the chosen PTVs were calculated. If there were no correlation, there would
be reason to suspect that the method is not truly adaptive.
The fraction number had a statistically significant (p < 0.001) negative (correla-
tion coefficient = –0.25) correlation with the bladder volume. The fraction number
also had a significant (p < 0.001) correlation with the Aarhus method PTV volume,
both with the modified and non-modified method. The correlation coefficients were
–0.26 in the case of the non-modified method and –0.31 for the modified method,
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Figure 19: The volumes of the patients’ PTVs chosen during the treatment averaged
across the fractions. Comparison of the modified methods with centroid registration.
Figure 20: The volumes of the patients’ PTVs chosen during the treatment averaged
across the fractions. Comparison of the actual methods.
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and thus the PTV volume decreases when the fraction number increases. The same
tendency was observed with the Helsinki PTV volumes (correlation coefficients –0.11
for the non-modified method and –0.07 for the modified method with the centroid
registration), but the correlation did not reach statistical significance. However, part
of the adaption comes from the positioning of the PTV according to the bladder in
the Helsinki method.
The correlation of the bladder volume to all PTV volumes was positive (0.45
and 0.47 for the non-modified and non-modified Aarhus methods and 0.44 and 0.33
for the modified and non-modified Helsinki methods) and the correlations reached
statistical significance for all the methods (p < 0.001). This was logical, since the
choices for the PTVs were made based on the daily bladders. There was also a
significant positive correlation between the mean PTV volumes chosen according to
each method, when the correlations were examined pairwise between all the methods
(p < 0.001).
4.2.4 Plan selection frequencies in simulation and in treatment
To see if the simulation realistically represents the methods, the treatment plans used
in the actual treatment were recorded. In the case of Helsinki method, only those
patients were included (1, 2, 3, 4, 8, 9), who had not had a treatment of the lymph
nodal regions. These patients had had a similar treatment as in the simulation, a
treatment to the bladder with the Helsinki method with the soft-tissue registration
(Figure 21a).
Compared to the treatment (Figure 21a), the selected plans in the simulation
were larger and the distribution of the plan selections was less even (Figure 21b).
The same tendency was observed when comparing the simulated (Figure 22b) and
actual (Figure 22a) Aarhus method plan selections. The plan selections in treatment
in AUH were obtained from the study of Vestergaard et al. [81] in order to see the
typical plan selection frequencies in the treatment according to the Aarhus method.
It needs to be emphasized that the patients in the treatment in AUH and the
patients in this simulation were different and therefore, the frequencies are not as
straightforwardly comparable than in the Helsinki method. The smaller plans were
more often selected for treatment in the real treatment than in the simulation.
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(a) HUCH treatment
(b) HUCH simulation
Figure 21: (a) Plan selection rates in the actual treatment in HUCH for the patients
who did not receive treatment of the lymph nodes. (b) Plan selection rates in the
simulation according to Helsinki method.
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(a) Aarhus treatment
(b) Aarhus simulation
Figure 22: (a) Plan selection rates in the actual treatment in AUH. Modified from
Ref. 81. (b) Plan selection rates in the simulation according to the Aarhus method.
The patients in the comparison are different since the treatment according to the
Aarhus method has been given in AUH. 13 of the AUH patients have also had their
lymph nodes treated [81], but they can be included in the comparison since the
Aarhus method employs bony-anatomy registration.
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4.3 Translations between bony-anatomy and soft-tissue reg-
istration
The systematic shifts between bony-anatomy and soft-tissue registrations (mm) in
different directions were listed for each patient (Figure 23). Some statistics of the
displacements were calculated (Table 8).
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Figure 23: Mean shifts between the registration based on bony anatomy and that
based on soft-tissue anatomy. The solid bars represent the mean shift in each direc-
tion. The error bars represent the range of shifts. Directions: x = left–right; y =
anterior–posterior; z = superior–inferior.
Table 8: The displacements between the registrations based on bony anatomy and
those based on soft-tissue anatomy.
Mean Median Mean SD Maximum
displacement displacement of patients displacement
[mm] [mm] [mm] (absolute value)[mm]
x: left–right 0.5 0.6 1.7 14.3
y: anterior–posterior –1.8 –1.5 3.5 16.5
z: superior–inferior –7.3 –6.5 3.4 25.3
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4.4 The CTV–PTV margin for lymph node treatment with
soft-tissue registration
The translations from soft-tissue anatomy to bony-anatomy registration coordinates
were used to calculate the individual means and standard deviations of the error due
to the soft-tissue registration in the hypothetical situation that the lymph nodes were
treated with soft-tissue registration. From these quantities, the overall mean error
M, the standard deviation of the systematic error Σ and the standard deviation of
the random error σ were calculated (Table 9).
Table 9: Individual means and standard deviations of the translations from bony
anatomy to soft-tissue registration during treatment. Based on these figures, also
the systematic mean error, the standard deviation of the systematic error, and the
standard deviation of the random error were calculated. Directions: x: left–right,
y: anterior–posterior, z: superior–inferior.
Individual mean Individual SD
Direction x y z x y z
Patient [mm] [mm] [mm] [mm] [mm] [mm]
1 –1.2 –1.2 6.2 1.0 4.4 3.0
2 3.0 1.7 4.6 1.3 2.3 2.7
3 –1.4 –2.2 3.4 1.4 2.3 1.9
4 0.4 3.6 7.6 1.3 4.0 4.4
5 –3.2 –5.8 4.4 1.9 3.2 3.8
6 5.1 1.1 14.3 3.3 2.8 4.1
7 0.6 –6.6 –3.5 1.3 4.1 2.3
8 –2.9 9.0 6.3 1.0 2.6 1.9
9 –5.4 7.8 17.0 3.0 5.5 5.8
10 0.3 10.3 12.8 1.9 3.8 3.7
M –0.5 1.8 7.3 σ 1.9 3.7 3.6
Σ 3.1 5.9 6.0
The margin based on the formula (3) was calculated for all directions x, y and
z. The margin in x direction was
mPTV,x = 2.5Σx + a+ β (σx − σp)
= 2.5 · 3.1 mm + 1.5 mm + 0.52(1.9 mm− 8.1 mm) = 6.0 mm.
The margin widths in the y and z directions were calculated respectively by using
the y and z direction values for the vector quantities. The margin widths in x, y and
z directions were 6.0 mm, 14.1 mm and 9.1 mm, respectively. The success of the
treatment fractions, were these margins used, was evaluated by checking whether
the margin is larger than the absolute value of the translation (Figure 24). If the
margin was inadequate, the treatment fraction was judged to be failed, even if a
small miss usually does not have an impact on the resulting total dose, unless it is
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repeated many times at the exactly same location. On average, 65% of the treatment
fractions would have been successful, would the van Herk margin have been used.
Figure 24: The number of successful treatment fractions with the margin of van
Herk [21], listed for each individual patient.
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5 Discussion
5.1 Bladder volumes observed during the treatment
The range of the bladder volumes observed during treatment was 42–343 ml. McBain
et al. studied bladder volume variation with cine-MRI imaging. In their cohort of 10
patients they observed similar empty bladder volumes of the range from 55–395 ml.
The imaging method is different and thus, the results should be interpreted carefully.
It could be awaited that the bladder volumes observed during treatment would be
larger than those observed when studying the empty bladder, since the treatment
cannot always be given immediately after the patient has voided their bladder. In
our study, this was not the case as the mean empty bladder volume in the planning
CT scans was 147 ml and the mean CBCT bladder volume was 127 ml. A similar
observation was made by Muren and colleagues [6]. Muren et al studied in total 129
repeat CT scans taken during the treatment of 20 patients and observed an overall
mean bladder volume of 143 ml [6]. The average planning scan bladder volume was
206 ml [6].
In 67% of the CBCT scans, the bladder volume was smaller than in the CT scan
with empty bladder. Similarly, in the study of Muren et al. the bladder volumes
were smaller than in the planning situation in 85% of the repeat scans [6].
In this study, also a trend of decreasing bladder volumes during the treatment
was observed. This trend was reported before by Pos and colleagues [63]. Mangar
and co-workers [88] found the bladder filling rate and bladder size to have been
unaffected by RT in their study but reported that the bladder filling rate could
have been found to be decreasing due to RT, had more patients been included.
Lebesque et al. found the bladder volume to decrease with time over the course
of the treatment [89]. McBain et al. found significantly decreasing bladder volume
during treatment in 5 of 20 patients and conducted that radiotherapy can directly
influence the physical properties of the bladder in some cases [46]. A similar trend
of bladder decrease during prostate cancer radiotherapy has been reported by many
authors [90–94].
Yee and colleagues found a similar trend of bladder decrease [4]. They reported
the CBCT-derived bladder and PTV volumes to be 10–17% smaller relative to those
derived from the planning CT. Yee and co-workers estimated this to be a result of
a combination of several factors. Firstly, the patient can develop a more consistent
daily bladder-emptying routine prior to RT during the course of the treatment.
Secondly, antitumour effects from RT may cause the bladder tumour to diminish,
facilitating improved bladder emptying [4]. Thirdly, acute RT cystitis may increase
the urinary frequency, which results in smaller bladder volumes during RT [4].
In some patients, exceptionally large bladder volumes were observed on some
fractions even though the bladder volume variation was otherwise of a smaller range.
These might be occasions when the patient has received chemotherapy. The hydra-
tion required prior to chemotherapy can increase the diuresis level and the bladder
filling rate [95]. One potential limitation of this study is that the bladder contours
were not delineated by a radiographer or an oncologist. However, the precision
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should be adequate for the purpose of the comparison between two methods, which
was the main goal of the study.
5.2 Modified methods
Combining the Helsinki method PSV formation method with the Aarhus method
margins and the bony-anatomy registration led to high number of fractions where the
largest PTV was inadequate. The number of fractions when the patient would have
had to void their bladder again was 100 out of 300, which would have slowed down
the treatment process immoderately. The combination of the PSV formation and
the Aarhus margins resulted in clearly too small PTVs to be used if bony-anatomy
registration is used.
Modifying the Helsinki method to employ Aarhus margins and the bony-anatomy
registration was not successful, as the method did not function properly after the
modifications. However, this analysis showed that if one wishes to use either of the
methods, they should not be modified. Also, the result shows that when creating a
method for adaptive radiotherapy of the bladder, one must consider precisely how to
apply previously developed methods to the current situation. Even a modification
that seems small can cause a large negative effect.
The other way to simulate the treatment with modified methods was to use
the centroid registration for both methods. In the Helsinki method, there are four
different plan selection volumes which are the bladder contours delineated in four
CT images acquired every 15 minutes starting from the post-void situation. The
Aarhus method PSVs are formed by using Boolean operations to achieve a composite
volume of the bladders in the first four treatment CBCT images and the planning
CT image, expanded with a 3-mm margin. In this simulation with the centroid
registration, this same 3-mm margin was applied to the Helsinki method CTVs to
form the PSVs.
The PSV formation method of HUCH was based on tracking the bladder filling
pattern. That of Aarhus was based on tracking the day-to-day positional variance
of the bladder. The other differences between the methods were equalized and the
Helsinki method used the margins of the Aarhus method and centroid registration.
The Aarhus method, on the other hand, employed centroid registration. When
making these equalizations, the following results were observed. The planning target
volumes chosen during the treatment in the simulation according to the Aarhus
method were on average larger than those of the Helsinki method. On the other
hand, there were some fractions with inadequate PTV volume with the Helsinki
method. The plan selections were more evenly distributed according to the Aarhus
method.
There were 22 fractions with the modified Helsinki method where the largest
PTV volume was inadequate to cover the bladder of the day. Either the margins
were insufficient or the centroid registration did not model the soft-tissue registration
sufficiently. These factors probably both had an effect. Asking the patient to void
again for 22 times out of 300 is still in the tolerable range and the method was hence
found to work adequately to be compared with the modified Aarhus method.
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The additional 3-mm margin made the plan selections of the Helsinki method
more evenly distributed than in the simulation of the actual Helsinki method. It
can be asked whether addition of this kind of a margin would be beneficial for
the method. Apparently there were many fractions in the simulation of the actual
clinically used Helsinki method, where the PSV volume was inadequate and the
limiting factor would necessarily not have been the PTV volume. If the plan selection
volumes are frequently too small even if the PTVs were not and thus cause the
unnecessary selection of larger PTV volumes, this is of course an unwanted situation.
However, the plan selections in the treatment have apparently been more evenly
distributed than in the simulation and also the smaller PTVs have been selected.
5.3 The actual methods
The basic ideas behind Helsinki and Aarhus methods are different. The Helsinki
method aims to record the individual pattern of bladder filling while Aarhus method
is based on recording the day-to-day positional variation of the bladder. The
strengths and possible weaknesses of the methods should be compared from these
points of view.
The positional variation is accounted for in the Helsinki method by using the
soft-tissue registration. The strength of this approach is that the planning target
volumes can be smaller when they can be moved to an optimal position with respect
to the bladder. Wright et al. found that an optimal translation with respect to the
bladder did not increase healthy tissue irradiation in comparison to no translation
[76]. Also, the optimal translation was superior in terms of normal tissue sparing,
when optimizing the PTV margins based on the daily bladder. The soft-tissue
registration is hence a logical option if one wishes to have the smallest possible PTV
volume.
With the PTVs accounting for bladder volume variation due to filling, the method
is not sensitive to those occasions when the bladder emptying has not been successful.
Bladder cancer patients might have difficulties in emptying the bladder properly and
asking the patient to go to the toilet again slows down the treatment, which can be
an important issue in a busy radiotherapy department.
The downside of the soft-tissue registration is that it is infeasible when treating
the lymph node areas. The lymph nodes remain in a stable position with respect
to the bony anatomy and thus, the current practice is to register the treatment
CBCT images to the treatment planning CT with the bony-anatomy registration
when treating these areas. In this study, the margin widths required for treatment
of the lymph nodal areas with soft-tissue registration were calculated and will be
discussed later.
The benefits of the bony-anatomy registration are that it is easy to perform and
that the lymph nodal areas can be treated at the same time without having to think
about any additional margins to the lymph nodes. However, there might be a need
for larger PTV options when registering the images based on bony anatomy and not
based on the bladder.
The limitation of the PSV formation based on the bladder filling pattern is
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that the optional PTVs are formed based on the situation of a single hour. If the
situation is unrepresentative of the situation in the treatment (e.g. the rectum filling
is exceptionally large), it might be difficult to find good options for the daily PTVs
during the treatment. In this case, larger PTVs get chosen more often and even
they might not be enough to suit the bladder. A renewed CT scan and treatment
planning might be acquired.
Using the bladder positional variation during the first four fractions and the plan-
ning scan as a starting point for the target volume formation is more robust to the
unrepresentative situations during one day. At worst, these situations merely cause
unnecessary expansion of the treatment volume and not the need for re-planning.
Five scans of the patient has been suggested to be optimal number of scans to form
the PTV [96], with which a reasonable part of the bladder positional variation is
captured to the composite volumes. This is essential, since the registration based
on bony anatomy does not in itself account for the variation of the bladder position.
One suboptimal issue in the Aarhus method is that it requires a week of irradia-
tion with larger margins. However, they have suggested giving the boost treatment
during the first week eliminating the need for the larger margins during the first few
fractions [81].
The actual Helsinki and Aarhus methods used in the treatment were compared
as such, non-modified. The comparison showed no statistically significant difference
between the methods. However, in the simulation according to the Aarhus method,
the selection frequencies of the alternative planning target volumes were more evenly
distributed, as for the Helsinki method, the large planning target volumes were the
most frequently selected. Based on this study, both methods are equal in terms
of normal tissue sparing, which is an encouraging result. Additional confidence in
the result would be achieved by including more patients to the comparison. The
respective studies have had similar numbers of patients (Table 3). The group of
10 patients included in this study was thought to be adequate but a larger group
would have been challenging, as the bladder delineation is time-consuming. The
PTV volume is a good measure of the healthy tissue irradiation, but to be able to
get more detailed information on the doses to specific normal tissues, it would be
interesting to calculate the daily dose distributions.
One limitation in the objectivity of the comparison was the lack of an auto-
matic soft-tissue registration algorithm, that is available on the treatment machine
in HUCH. The plan selections according to the Helsinki method based on soft-tissue
anatomy were done by using the centroid registration as a starting point and trying
to make as little translation as possible. However, basically the optimal position of
the bladder could be searched arbitrarily. At the treatment machine, the radiog-
raphers can make adjustments to the result of the automatic registration. Careful
consideration was obeyed when making adjustments, keeping the reasonable scale
of translations in mind. The Aarhus method simulation based on bony-anatomy
matching did not have this same limitation.
The plan selection frequencies in treatment and in the simulation were compared
to see how well the simulation represented the clinical situation for both Aarhus and
Helsinki methods. An interesting observation was that the largest PTV alternatives
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are the ones the most frequently chosen, as the frequencies of the treatment plans
chosen in the real treatment are not like this. Before drawing any conclusions of
the methods and in which situations each of them should be applied, one has to
consider how well the simulation represents the methods in treatment.
The PTVs used in the treatment are always situation-based and depend on the
decisions made by the physician. This is known to be the situation at least in HUCH
and this kind of variation exists also in AUH [81]. Therefore, the size of the volumes
used in the simulation and those used in the treatment might differ.
In the comparison of the plan selection frequencies between simulation and treat-
ment according to the Helsinki method, the amount of data of the plan selection rates
in the treatment was modest. This was due to the fact that some patients included
in the study (patients 5, 6, 7 and 10) had received a treatment of the lymph nodal
areas in addition to the whole bladder irradiation. With these patients, the planning
target volumes naturally differ drastically between the simulation and treatment and
since also the registration method in these cases differed from the reported method,
these patients were decided to be left out of the analysis. The remaining data for
six patients may not be enough to give a comprehensive view on the plan selection
frequencies in HUCH in general. However, the comparison was considered to give
some idea of how well the study simulated the real situation.
For Aarhus method, there was more data to compare the simulated plan selec-
tions with. In a recent study of Vestergaard et al., the plan selection frequencies
during the treatment of 20 patients were reported [81]. The patients in the treat-
ment were thus not the same as in the simulation. Individual differences occur but
in addition to those, there might be differences between the AUH and HUCH pro-
tocols. As many as 13 patients of this group had received lymph node treatment in
addition to whole bladder irradiation [81], but the patients could be included in this
comparison, because Aarhus method employs bony-anatomy registration. Naturally,
treating the pelvic lymph nodes added extra space to the bladder PTV especially
in the cranial direction where the lymph nodal PTV and bladder PTV overlap.
In AUH, patients are given frequent feedback of the bladder emptying success of
the day and also, if the bladder emptying seems not to have been successful, the pa-
tient is sent to the toilet. The Helsinki method PTVs, on the other hand, are formed
based on the bladder filling pattern of the patient and even though the patients are
instructed to come to the treatment with an empty bladder, the patient is not nec-
essarily asked to void again in case of an unexpected delay between the voiding and
the treatment. Since the simulation is done with imaging information of the HUCH
patients, the Aarhus method requirements of a totally empty bladder might not be
fulfilled, increasing the chosen PTV volumes. One additional difference to be con-
sidered is that in AUH, rotational corrections around the anterior–posterior axis are
possible whereas this simulation included only translational corrections. It should
be mentioned, though, that the possibility to correct the couch rotational deviations
is a relatively new addition to the AUH protocol. Hence, some of the patients in the
Vestergaard and colleagues’ study [81] might have been treated without correcting
the couch rotation around the anterior–posterior axis.
During the treatment, different people make decisions of the plans of the day.
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The criteria for plan selection might not have been exactly the same despite the
instructions. At least in HUCH there has been some evolution in the protocol for
plan selection. It was reported in the paper of Tuomikoski et al. [9] that the plan
selection was done by seeing that the bladder of the day fit into the PTV with a
margin of 3 mm, at that time thought to sufficiently account for the intrafractional
bladder filling. Hence, it is not straightforward to compare these plan selection
frequencies.
The level of uniformity of the protocols might be different in AUH and HUCH,
since it is reported that the people working with the adaptive treatments all have
to take a course in AUH [81]. However, for both methods, inter-observer variation
might affect the plan selections in the treatment. In the simulation this inter-
observer variability is eliminated, since all the decisions about the plans are made
by a single observer. The variability is further decreased by having the CBCT
bladder contours visible during plan selection. Observing if the bladder contours
fit inside the plan selection volume makes the procedure reproducible and reduces
errors. However, this might not represent the real life plan selection, where one pixel
of the bladder can be outside the plan selection volume and is left unnoticed. An
error of this scale is insignificant to the treatment result. Also, the imprecision of
the hand while delineating the bladder might lead to situations where the bladder
contour crosses the plan selection volume contour and leads to selection of a larger
PTV volume even if the border of the bladder would in reality have fitted into the
PSV. This is true for Aarhus method as well as for the Helsinki method.
One reason for the selection of on average larger PTVs in the Helsinki method
simulation might also be that in the group of 10 patients included to the study,
there were two patients with a peculiar-shaped elongated bladder. If the bladder is
in a different position in the planning CT image than in the treatment, the effect is
larger with an unusually long bladder, compared to the regularly shaped one. The
special shape of the bladder is better accounted for in the Aarhus method, where
the composite volumes of the bladders during the first fractions are more likely to
compensate for the effects of bladder form changes. An unrepresentative planning
scan situation may have stronger effects on the success of the Helsinki method, and
also in this simulation there was at least one patient with rectum filling during the
planning CT scans.
5.4 The CTV–PTV margin for lymph node treatment with
soft-tissue registration
The formula (3) which was introduced by van Herk [21] accounts for only the devi-
ations of the random and systematic errors and assumes the mean systematic error
M to be small [16]. The authors note that this error often deviated significantly
from zero because of inaccuracy of the equipment (lasers) and procedure [16]. These
deviations are small.
The situation in this simulation of the treatment including the lymph nodes is a
bit different from the prerequisites of van Herk and co-workers [16]. In this case, we
intentionally correct the error in the bladder positioning and therefore produce an
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error to the lymph nodes. Thus, for the lymph nodes, the mean error M deviates
from zero in all directions. The magnitude of the mean translation on a population
basis is unknown and cannot be determined with the sample of 10 patients included
into this study. It would thus require additional analyses to clarify whether the
formula of van Herk (3) [21] is truly applicable to this situation.
For the purposes of this simulation, the van Herk formula (3) is adequate, since
the systematic error correction would not have to increase the margin. A reasonable
strategy to take the systematic error into account, margin would be added in the
direction of the error and reduced from the opposite side. Of course, the direction
of the error would be hard to estimate in advance, but for the simulation of the
lymph node treatment with the soft-tissue registration, the van Herk margin is a
good guess for the margin width extending the PTV.
Van Herk et al. calculated their margin recipe on the basis of a dose–population
histogram and it should ensure that for 90% of the patient population, the minimum
dose to the CTV must be 95% of the nominal dose or higher [21]. If this requirement
is filled or not, is difficult to estimate based on this approach of merely comparing
two digits. If, for example, the bladder would on one treatment fraction be 1 mm out
of the PTV, this would not have a devastating effect in reality. However, when just
checking if the margin is larger than the translation, this fraction would be judged
as missed. Therefore, it is likely that the calculated margin would in fact lead to
the situation defined by van Herk. On average 65% of the treatment fractions were
judged to succeed in this analysis and it is likely that considering the severity of the
misses, the goal set by van Herk [21] could be achieved.
The margin was not sufficient for patients 6, 9 and 10. There were only 2 success-
ful treatment fractions for patients 6 and 9 and 4 successful treatment fractions for
patient 10. These patients had a large positive mean shift (14.3 mm, 17.0 mm and
12.8 mm) in the z-direction. This indicates that CBCT image was moved cranially
when changing the registration from the bony-anatomy registration to soft-tissue
registration. The other patients had much smaller translations in the z-direction
(Figure 23).
The margin widths calculated with the van Herk formula (3) were realistic (the
margin in x, y and z-directions 6.0 mm, 14.1 mm and 9.1 mm, respectively). There
are two options: to add a larger margin to the lymph nodal areas and match based
on the bladder or to add a larger margin to the bladder and register the images
based on the bony anatomy. The treated volume can be reduced if the latter option
is chosen. Hence, those patients whose condition requires treatment of the lymph
nodes should have the treatment CBCT-images and the treatment planning CT
image registered based on the bony anatomy, which is the current practice also in
HUCH, where soft-tissue registration is usually employed. One option would be to
use the Aarhus method in the cases when the bony-anatomy registration has to be
applied, since the method already employs matching based on the bones.
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6 Conclusions
Urinary bladder adaptive radiotherapy has been shown to both avoid target misses
by increasing precision and enable smaller target volumes in the treatment. This
leads to fewer side effects and can enable dose escalation, which has been suggested
to improve the outcome of the bladder cancer radiotherapy. However, up to this
point, no consensus of the optimal strategy of adaptive bladder radiotherapy has
been reached.
In this study two bladder ART methods were compared by means of a simulated
treatment. The Helsinki method was based on tracking the individual bladder filling
pattern of the patient. The bladder contours with different filling status were used
to form the alternative CTVs. The idea of the Aarhus method was to record the
bladder positional variations during the first fractions of treatment and to use these
in order to form the CTVs. For 10 patients, the bladder contours in CBCT images of
30 treatment fractions were contoured. Using these contours as an objective measure
of whether the bladder of the day fit inside the plan selection volume contour, the
daily PTVs were chosen according to both methods.
The original aim was to study the impact of the PSV formation method to the
results. The way to form the PSV was one of the three differences between the
methods. The other differences were the PSV–PTV margins and the method to
register the treatment planning CT to the treatment CBCT images when adjusting
the patient’s position. The aim was to equalize the other differences between the
methods to be able to solely compare the impact of the PSV formation method.
The first way to equalize the differences between the methods was to employ
bony-anatomy registration and Aarhus method margins for both methods. This
combination with the Helsinki PSV formation method resulted in clearly too small
PTVs and the comparison with the Aarhus method would not have been reasonable.
Since the comparison using Aarhus method margins and registration methods
was unsuccessful, the second option to compare the methods was to still use Aarhus
method margins, but to register the images based on soft tissues as in the Helsinki
method. It was thought that if soft-tissue registration would be used for both
methods in the comparison, the objectivity of the matching would be hard to en-
sure. There was no automatic algorithm available for this simulation, although the
registration of the images is done automatically on the treatment machine. A com-
promise was made to use the centroid registration, where the mass gravity centres
of the bladder and PSV contours would coincide, for both methods. The Aarhus
method margins were again used for both methods.
Using centroid registration had only a minor effect on the Aarhus method. The
Helsinki PSV formation method, however, combined with the centroid registration
and the Aarhus margins resulted in significantly smaller PTV volumes compared
to the modified Aarhus method with the centroid registration. The PTVs were
evenly selected in the simulation of both methods, but even more so according to
the Aarhus method, where also the smaller PTVs were chosen more often.
In addition to the comparison of the modified methods, the methods were com-
pared as such, as used in the treatment. There was no statistically significant
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difference between the methods in terms of normal tissue sparing. The plans were
again distributed more evenly according to the Aarhus method. It was noticed that
the plan selections included the smaller alternative plans more often according to
the modified Helsinki method where the PSV is formed by expanding the CTV with
a 3-mm margin than according to the actual method where the PSV is the CTV.
Thus, it might be a reasonable improvement to the Helsinki method to increase the
plan selection volume margin. However, the plan selections in the actual treatment
were compared to the simulation and it was observed that the smaller plans had
been more frequently selected in the treatment than in the simulation. The daily
bladder contours used in the simulation for the sake of objectivity might have had an
effect on the plan selection frequencies, which on the other hand might have had an
effect on the mean PTV volumes. It would be useful to repeat the analysis without
having the contours visible to see how the plan selection would be without contours,
even with concerns of objectivity.
Both methods have their strengths as well as their downsides. The soft-tissue
registration of the Helsinki method is a logical choice if one wishes to get the full
potential out of image guidance. Also, since the Helsinki method is based on track-
ing the bladder filling pattern, empty bladder is not necessarily required to the
treatment, which can be beneficial when treating patients with urinary deficiency.
In Aarhus those patients who have difficulties in consistently voiding their bladder
would benefit of a treatment according to the Helsinki method.
The simulation of treatment with soft-tissue match encouraged to continue using
the bony-anatomy match when treating the lymph nodal regions in addition to whole
bladder irradiation. This is the practice in HUCH. However, it is not clear whether
the mean volume of the selected planning target volumes is the same according to
the Helsinki method using soft-tissue registration and the bony-anatomy match and
thus, one cannot know if a similar reduction of treatment volumes can be gained
with the bone registration combined with the Helsinki method. With the Aarhus
methods these patients would get the treatment according to a well established
protocol that is designed to work with bony-anatomy registration. I recommend
using the Aarhus method for these patients.
The Aarhus method is not as sensitive as the Helsinki method to an unrepre-
sentative situation in the planning scan. For HUCH I would suggest replanning
the treatment according to the Aarhus method in the cases when there is reason to
believe that the planning scan failed to represent the treatment situation. The first
week’s treatment could be given with the Helsinki method and if the largest PTV
had been frequently selected merely because the patient’s anatomy had changed
from the treatment planning CT, the Aarhus PTVs could be designed based on the
first CBCT scans. However, it needs to be emphasised that this hasn’t frequently
occurred in treatment.
The main finding of this study was that there was no difference in the mean
PTV volume for the study population of 10 patients. Since both Helsinki and
Aarhus methods have been found to result in diminished small bowel irradiation
compared to the conventional bladder cancer radiotherapy treatment, no method
can be judged superior to the other regardless of the situation.
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